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Abstract
Case-noncase studies, also known as case-control studies, are ubiquitous in epi-
demiology, where a common goal is to estimate the e↵ect of an exposure on an outcome
of interest. In many areas of application, such as policy-informing drug utilization re-
search, this e↵ect is inherently causal. Although logistic regression, the predominant
method for analysis of case-noncase data, and other traditional methodologies, may
provide associative insights, they are generally inappropriate for causal conclusions.
As such, they fail to address the very essence of many epidemiological investigations
that employ them. In addition, these methodologies do not allow for outcome-free
design (Rubin, 2007) of case-noncase data, which compromises the objectivity of re-
sulting inferences.
This thesis is directed at exploring what can be done to preserve objectivity in
the causal analysis of case-noncase study data. It is structured as follows.
In Chapter 1 we introduce a formal framework for studying causal e↵ects from
case-noncase data, which builds upon the well-established Rubin Causal Model for
prospective studies.
In Chapter 2 we propose a two-party, three-step methodology — PrepDA — for
objective causal inference with case-noncase data. We illustrate the application of
our methodology in a simple non-trivial setting. Its operating characteristics are
iii
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investigated via simulation, and compared to those of logistic and probit regression.
Chapter 3 focuses on the re-analysis of a subset of data from a published arti-
cle, Karkouti et al. (2006). We investigate whether PrepDA and logistic regression,
when applied to case-noncase data, can generate estimates that are concordant with
those from the causal analysis of prospectively collected data. We introduce tools for
covariate balance assessment across multiple imputed datasets. We explore the po-
tential for analyst bias with logistic regression, when said method is used to analyze
case-noncase data.
In Chapter 4 we discuss our technology’s advantages over, and drawbacks as com-
pared to, traditional approaches.
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Chapter 1
Framework for causal inference in
case-noncase studies
1.1 Introduction
1.1.1 The case-noncase study
The case-noncase study, also known as case-control study, is ubiquitous in epi-
demiology and biostatistics for screening factors suspected to be associated with rare
diseases, and for quantifying how disease risk varies with said factors. It is, in fact,
uniquely suited to the study of rare diseases, for which prospective cohort studies are
often impractical due to prohibitive costs and restrictive logistics. A cohort study, for
instance, may require follow-up of a sizable study population — possibly over an ex-
tensive period of time — to insure data collection on an adequate number of diseased
units. In contrast, the case-noncase study generally allows for a faster and less costly
1
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investigation via selection of study subjects based on the outcome of interest. That
is to say, the study starts after outcomes have been realized (and possibly observed).
As such, the case-noncase design is retrospective and non-randomized (randomization
cannot be used to assign units to particular treatments or regimes).
In its simplest form, the case-noncase study examines the relationship between a
single pre-specified binary treatment and a binary outcome. For example, in policy-
informing drug utilization research, the study might concern the e↵ect of taking or
not taking a particular medication (the treatment) on the subsequent occurrence or
non-occurrence of disease (the outcome). In case-noncase jargon, individuals with a
particular disease or condition are called ‘cases’, whereas those without the disease
or condition are called ‘noncases’1. After all outcomes have been realized, cases and
noncases are sampled with di↵ering probabilities. Cases are oversampled as a means
to get around the issue of outcome rarity. We consider the scenario in which all
cases have been sampled. This can be accomplished, say, through data collection via
surveillance programs and registries. Noncases, on the other hand, are commonly
selected via simple random sampling from an underlying cohort, whose existence is
guaranteed under the setup of a case-cohort design2 (Prentice, 1986), or by means of
retrospective matching (Holland and Rubin, 1988). In this thesis we do not address
studies of the latter type because retrospective matching is, in our opinion, an oft-
misleading and generally inadequate method for pretreatment bias reduction in causal
e↵ect estimation (see Section 1.2.9). Instead, we focus on studies of the former type.
1Our use of the ‘noncase’ terminology intends to avoid confusion between the meanings of control
as in non-occurrence of disease, and control as in non-exposure to active treatment.
2In a case-cohort design, a subcohort of noncases is randomly selected from a well-defined cohort.
2
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Henceforth, we assume as research goal the quantification of the causal e↵ect of a
possible disease-causing treatment on an outcome of interest.
1.1.2 A brief literature review of the statistical analysis of
case-noncase data
According to Breslow and Day (1980), an implementation of the case-noncase
study was first reported in Lane-Claypon (1926). It was not until two decades later,
however, that research articles on methodology and the statistical analysis of case-
noncase data surfaced. Of particular importance were the classical Cornfield (1951)
and Mantel and Haenszel (1959) papers. Cornfield (1951) showed that it was possi-
ble to estimate a relative risk from case-noncase data. Mantel and Haenszel (1959)
introduced the  2 measure of statistical significance and a pooled estimator of rela-
tive risk. Mantel and Haenszel (1959) also discussed the role and limitations of the
case-noncase design, and emphasized its relationship to cohort studies. Cornfield’s
early work gave way to a series of notable papers on the estimation of (log-)odds
ratios (see, e.g., Woolf, 1955; Haldane, 1955; Gart, 1966). The 1970s brought gen-
eralizations of relative risk and odds ratio estimates to case-noncase designs with
retrospective matching (e.g., Miettinen’s (1970) estimation of relative risk from indi-
vidually matched case-noncase studies).
An important subsequent development was the demonstration that logistic regres-
sion can be applied to the (associative) analysis of case-noncase data (Anderson, 1972,
1973; Mantel, 1973; Seigel and Greenhouse, 1973; Prentice and Pyke, 1979). Pren-
tice and Pyke (1979), in particular, demonstrated that the “[odds ratios’] asymptotic
3
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variance matrices may be obtained by applying the original logistic regression model
to the case-control study as if the data had been obtained in a prospective study”.
Logistic regression has since become the predominant method for the analysis of
case-noncase study data. Gefeller et al.’s (1998) literature survey revealed a dramatic
increase in its use over the 1955-1994 period: its rate of implementation rose from
18.4% in 1955, to a staggering 87.2% in 1994.
Among recent developments is Rose and van der Laan’s (2009b; 2009a) work on
nonparametric estimation of marginal causal e↵ects from (retrospectively matched)
case-noncase data via weighted targeted maximum likelihood estimation.
1.1.3 Causal inference under the Rubin Causal Model
The statistical framework for causal inference based on the idea of potential out-
comes was first proposed by Neyman (1923) for randomized experiments. It was
extended by Rubin (1974, 1977, 1978a) to non-randomized studies under a formal
structure now commonly called Rubin’s Causal Model (RCM, see Holland, 1986).
The RCM consists of three components. The first is a set of fundamental notions:
unit, treatment, covariate and potential outcomes. The second is the concept of an
assignment mechanism. The third, and optional, component is a Bayesian model.
We briefly outline each of these components below. The reader is referred to Imbens
and Rubin (2015) for a comprehensive reference on the topic of causal inference in
statistics, social sciences, and biomedical sciences under the RCM.
The first part of the RCM introduces four fundamental notions: unit, treatment,
covariate and potential outcomes. A unit is a person or physical object at a partic-
4
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ular point in time. Suppose that each unit in a study is subject to two treatments,
or interventions (e.g., an active treatment and a control treatment) whose e↵ects we
wish to assess. For each of these units, we define the two potential outcomes (assum-
ing SUTVA, see Holland, 1986) as the outcome that would be realized (an possibly
observed) under the control treatment, and the outcome that would be realized (and
possibly observed) under active treatment. Note that it is possible for outcomes to
be realized but not observed. This can occur, for example, in a case-noncase study: a
unit’s outcome, although realized, will not be observed by the investigator if the unit
under consideration is not selected into the case-noncase sample (see Sections 1.2.5
and 1.2.6 for further discussion). Because at most one of the treatments can be ap-
plied at any given time to any given unit, only the potential outcome corresponding to
said applied treatment is realized, and hence observable. The other, i.e. the outcome
that would have been realized had the alternative treatment been applied, is miss-
ing (Fundamental Problem of Causal Inference Holland, 1986). Accordingly, causal
inference, or the inference of causal e↵ects — which in turn are defined as the com-
parison of units’ potential outcomes under the two treatments — can be formulated
as a missing data problem. In tackling this problem, it is desirable to compare units
in the active treatment group to those units from the control treatment group who
share similar background characteristics. As such, causal inference methods generally
take into account units’ covariates, which are defined to be background characteristics
that could not have been a↵ected by treatment assignment.
The second component, the assignment mechanism, gives the probability of being
assigned to the active treatment for each unit in the study as a function of units’
5
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covariates and, possibly, units’ potential outcomes. This mechanism plays a central
role in causal inference as it explains the occurrence of missing potential outcome
data. What’s more, the assignment mechanism enables researchers to understand,
formulate and explicitly state any assumptions (e.g., unconfoundedness of the assign-
ment mechanism, see Rubin, 1975; Imbens and Rubin, 2015) made in reaching causal
conclusions.
The third, and optional, component of the RCM is a Bayesian probability model
on the science, which is understood to be the triplet consisting of covariates, the
potential outcome under active treatment, and the potential outcome under control
treatment, for all units in the population. (The science, as such, is the object of
causal inference.) The probability model is generally used by analysts to either (a)
infer relevant super-population parameters, or (b) impute missing potential outcome
data via posterior predictive sampling for purposes of finite-population inference.
1.1.4 Outcome-free design for objective causal inference
According to Rubin (2007), “typically in order to get a drug approved, US Food
and Drug Administration (FDA) requires carefully specified randomized designs and
carefully specified primary analyses and secondary supporting analyses, and often the
data collection and first pass analyses are carried out by a [sic] agent independent
from the organization trying to get approval for the drug. There is thus tremendous
pressure to live with the answers that come from the pre-specified design and anal-
yses.” This modus operandi ensures objectivity in the investigation of causal e↵ects
from randomized experiments.
6
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In contrast, “observational studies are generally fraught with problems that com-
promise any claim for objectivity of the resulting causal inferences” (Rubin, 2008).
In regression adjustment, for instance, study design is not separated from outcome
analysis. For this reason, it is both possible and tempting for researchers “to fish
for a certain result, [by] fitting several models until the desired or expected answer
appears” (Pattanayak et al., 2011). Chapter 3 explores this idea in the context of
case-noncase data analysis.
Accordingly, Rubin (2007) advocates that “observational studies can and should
be designed to approximate randomized experiments as closely as possible... [These
studies] should be designed using only background information to create subgroups
of similar treated and control units, where similar here refers to their distributions of
background variables. Of great importance, this activity should be conducted without
any access to any outcome data, thereby assuring the objectivity of the design.” By
‘design’, Rubin means all contemplation, collection, organization, and analysis of data
that takes place prior to seeing any outcome data.
We henceforth define ‘objective’ causal inference as that whose design phase is
‘blinded’ to outcome data. Although ‘blinded causal inference’ might, as such, be
more fitting terminology for the topic discussed in this thesis, we proceed with the
term ‘objective’ for purposes of consistency with Rubin (2007).
7
Chapter 1: Framework for causal inference in case-noncase studies
1.1.5 Case-noncase study applications, and the need for ob-
jective and causal inference
Applications of case-noncase studies span a wide and diverse range of fields, from
public health policy, to drug utilization research, to litigation support. For example,
Centers for Disease Control and Prevention (CDC) investigated in 2006 the associa-
tion between Fusarium keratitis, a rare and dangerous fungal infection of the cornea,
and use of Bausch & Lomb’s ReNu with MoistureLoc R  contact lens solution. The
agency concluded an increased risk for Fusarium keratitis associated with use of the
solution (Barry et al., 2006). These findings had regulatory, market, and litigative
implications. Soon after the agency posted its report, FDA recommended that “con-
sumers... stop using ReNu with MoistureLoc R  immediately” (Schultz, 2006). A
month later, Bausch & Lomb announced its decision “to voluntarily recall and per-
manently remove this contact lens solution from the worldwide market” (Barry et al.,
2006). It is reported that between 2008 and 2009, Baush & Lomb has “settled nearly
600 fungal-infection lawsuits” (USA Today, 2009). Another example is Raz et al.
(2014), a topical study that found a positive association between maternal exposure
to particulate matter air pollution, and odds of autism spectrum disorder (ASD).
Said article got reported by several media outlets soon after its publication (e.g.,
Gallagher, 2014), and is likely to fuel further discussion on the link between autism
and pollution.
It can be argued that both these studies, in character with most medical science
investigations, were conducted with a view to inform policies. (As a matter of fact,
Raz et al. (2014) concludes that “air pollution is a modifiable risk factor for autism,
8
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and reduced exposure during pregnancy could lead to lower incidence of ASD and re-
duce the substantial, increasing economic burden of ASD on families and on society”.)
CDC’s investigation proved to be notably impactful in that regard.
Nonetheless, although associative studies are adequate for exploratory purposes
and can be relied upon for the instatement of reasonable precautionary measures
(e.g., e↵orts should be made to mitigate risk of Fusarium keratitis), they are generally
inappropriate for policy making (recollection of ReNu with MoistureLoc R , if not a
causative agent of Fusarium keratitis, is arguably unfair to Bausch & Lomb and its
shareholders). In our view, policy makers should, instead, strive to rely on causal
findings.
When analyzing case-noncase data for purposes of causal inference, we believe that
an e↵ort should be made to (a) work under a formal causal framework specifically
tailored to retrospective designs, (b) state, within the confines of this framework, all
assumptions made in reaching conclusions, and (c) of great importance, design the
study, pre-analysis, without access to any outcome data. While conceptually straight-
forward for cohort studies, outcome-free design is complex for the case-noncase de-
sign. Any one-party, one-step design methodology without access to outcome data
is infeasible: by design, sampling of units is conducted as a function of realized po-
tential outcomes, which in turn induces dependence between treatment assignments
and realized potential outcomes in the case-noncase sample (see Section 1.2.5). Con-
sequently, this invalidates the naive implementation of matched sampling methods
to case-noncase data. In Section 2.1, we propose a two-party, three-step method-
ology that circumvents this problem. To our knowledge, such methodology, along
9
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with a formal Rubin Causal Model-based framework for studying causal e↵ects from
case-noncase (or more generally, retrospective) data, has not been proposed to date.
1.2 A causal framework for case-noncase studies
In this section we introduce a formal framework for studying causal e↵ects from
case-noncase data, which extends the well-established Rubin Causal Model to retro-
spective studies.
1.2.1 The case-noncase study as a cohort study with missing
data
We frame the case-noncase study as a (hypothetical) prospective cohort study
with missing data (see Figure 1.1 below). Specifically, the data missing from this (hy-
pothetical) cohort consists of covariate, treatment assignment, and potential outcome
data for the non-sampled noncases — the non-sampled units, — and non-realized po-
tential outcome data for all cases and those sampled noncases — the sampled units.
We believe that this missing data formulation has the benefit of conceptually ty-
ing retrospective studies to their underlying prospective cohort studies, for which
there exists an array of well-accepted methods for objective causal e↵ect estimation
(e.g., see Rubin, 2006; Imbens and Rubin, 2015). In Sections 1.2.2 through 1.2.8, we
expound our missing data framework, under which our methodology, introduced in
Chapter 2, operates.
10
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Figure 1.1: The case-noncase study as a cohort study with missing data. Adapted
from Greenberg et al. (2004).
To be clear, the idea of the case-noncase study as a missing data problem is
not new: this view was advocated by Wacholder in a 1996 Epidemiology paper (see
Wacholder, 1996). Our work, however, departs from Wacholder’s (and others’), in
that (a) we focus on laying a formal framework for drawing causal inferences from
case-noncase study data which involves, but is not limited to, missing data theory,
(b) we put forward a methodology that enables objective estimation of causal e↵ects
from case-noncase data, and (c) our approach relies on multiple imputation, and is
inherently Bayesian.
In e↵ect, the inferential approach taken in Section 2.2 of this thesis is that of “cal-
ibrated Bayes” (Little, 2006). That is, while our method for inference is — in part —
Bayesian, its properties are evaluated under the frequentist paradigm. In addition,
our inferential framework is phenomenological, in that it focuses on observable values.
Rubin (1978b), arguing in favor of this approach, notes that “[t]here do not exist pa-
11
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rameters except under hypothetical models; there do, however, exist actual observed
values and values that would have been observed. Focusing on the estimation of pa-
rameters is often not what the applied person wants to do since a hypothetical model
is simply a structure that guides him to do sensible things with observed values.”
Lastly, in the spirit of the Rubin Causal Model, throughout this thesis we separate
well-defined, observable objects of inference (e.g., the finite-population average causal
e↵ect), from the process by which the investigator learns about said objects of infer-
ence (e.g., the case-noncase study as a prospective observational study design with
missing data), from the assumptions and statistical methods employed to estimate
said quantities of interest (e.g., unconfoundedness, Bayesian multiple imputation).
This approach contrasts with the commonly used techniques in the epidemiological
literature (see Section 1.1.2) which generally, from the onset, define estimands as
parameters embedded in some posited statistical model, without placing particular
emphasis on question definition nor framework setup (nor pre-analysis design).
1.2.2 Population cohort and sample cohort
We define two notions — population cohort and sample cohort — to distinguish
between two central sets of units, to which we allude throughout this thesis. We
define population cohort3 as the prospective cohort study population from which
case-noncase data is sampled retrospectively, if such population exists (e.g., under a
case-cohort design). Otherwise, we define the population cohort as the hypothetical
3The term source population has instead been previously used in various epidemiology papers.
We believe that the term population cohort has the advantage of directly alluding to the sampling
nature of the case-noncase problem.
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prospective cohort study population from which case-noncase data is assumed to
have arisen. Analogously, we define sample cohort as the set of units retrospectively
sampled from the population cohort — this is the case-noncase sample.
The population cohort is the finite population of inference. That is to say, it is
generally the population of interest to the investigator. For that reason, we do not
attempt to infer anything about units outside this population in Chapter 2 of this
thesis, which focuses on finite-population inference. Consequently, the process by
which the population cohort is selected, e.g., by taking a simple random sample from
some larger (super-)population or by virtue of availability of census data or hospital
records, is immaterial to the finite-population analysis, but for the instance in which
a super-population model is assumed for inferential purposes, as will hold true in
Section 2.2.
1.2.3 Population cohort: complete (observable) data
The framework introduced here builds upon the well-established Rubin Causal
Model for prospective cohort studies. The concept of unit, and notions of treatment,
covariate, and potential outcomes — all of which are observable quantities — all hold
under our framework, and apply to units in the population cohort. We supplement
these ideas with the concept of potential sampling indicators, which we define below.
We begin by introducing notation, which readers acquainted with the RCM should
find familiar. Let the population cohort consist of N units4, indexed by i = 1, · · · , N .
Associated with each unit is a 1 ⇥ k vector of covariates, xi. Let X denote the
4Henceforth, unless specified otherwise, “unit” is understood to mean “population cohort unit”.
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N ⇥ k matrix consisting of all units’ covariates. Further, let W denote the vector
of assignments. The components Wi of W indicate exposure to active treatment
when equal to 1, and zero otherwise. Under SUTVA (Holland, 1986), Yi(0) and Yi(1)
denote the potential outcome values of unit i under control treatment and active
treatment, respectively. We let Yi(w) = 1 if unit i is a case when Wi = w, and
Yi(w) = 0 otherwise. Collectively, variables Y (1) and Y (0) constitute the N vectors
of potential outcomes, under active treatment and control treatment, respectively.
Drawing an analogy to potential outcomes, we introduce the idea of potential
sampling indicators. The two potential sampling indicators associated with each unit
are the indicators for inclusion of the unit in the sample cohort under each of the two
treatment regimes. That is, we define unit i’s potential sampling indicators as the
sampling indicator that would be realized under control treatment and the sampling
indicator that would be realized under active treatment. We denote the two variables
by Si(0) and Si(1), respectively, and let Si(w) = 1 when unit i is included in the
cohort sample if assigned to treatment w, and 0 otherwise. For example, S3(0) = 1
and S3(1) = 0 signifies that unit 3 would be sampled under control treatment, but not
under active treatment. Note that, because only one treatment can be applied to any
given unit at any given time, only the potential sampling indicator corresponding to
said applied treatment is realized; the other, namely, the potential sampling indicator
corresponding to the alternative treatment, is missing. Also note that our definition
tacitly assumes that the potential sampling indicator for any unit does not vary with
treatments assigned to other units. We call this assumption SUTVA-S, analogously
and in reference to SUTVA (Holland, 1986):
14
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Assumption 1 (Stable Unit Treatment Value Assumption for Sampling
(SUTVA-S)). The potential sampling indicators for any unit do not vary with the
treatments assigned to other units.
More generally, for each unit i in the population cohort and treatment assignment
vector W , we let variable Si(W ) denote the potential sampling indicator of unit i
under treatment assignment vector W . We then let Si(W ) = 1 if unit i is sampled
under assignment configuration W , and Si(W ) = 0 otherwise. This generalized
notation would be used, for example, in a study in which sampling under allocation
of 10% of units to active treatment, say, is of interest. SUTVA-S, however, does hold
under the case-noncase setup considered throughout this thesis. We therefore let
S(1) and S(0) denote the column potential sampling indicator vectors under active
treatment and control treatment, respectively.
Ultimately, observable population cohort data consists of (a) the vectors of po-
tential sampling indicators S(0) and S(1), (b) the vector of assignments W , (c) the
vectors of potential outcomes Y (0) and Y (1), and lastly (d) the matrix of covariates
X. We represent these variables jointly by the complete data matrix Y˜
compl
:
Y˜
compl
= (S(0),S(1),W ,Y (0),Y (1),X) (1.1)
1.2.4 Causal estimands
A causal e↵ect is defined as the comparison of potential outcomes under active
treatment and control treatment. A finite-population causal estimand is any function
of the triplet (Y (0),Y (1),X) that satisfies the definition of causal e↵ect.
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Let Y¯ (0) = 1N
P
i Y (0) and Y¯ (1) =
1
N
P
i Y (1). In Table 1.1 below, we define
three causal estimands of public health interest: the risk di↵erence, the relative risk,
and the odds ratio.
Table 1.1: Three primary causal estimands for dichotomous outcomes. Adapted from
Chretien (2010).
Epidemiological
term
Finite population
estimand
Super-population estimand
Risk Di↵erence (RD) ⌧FP = Y¯ (1)  Y¯ (0) ⌧SP = ESP [⌧FP ]
= Pr(Y (1) = 1)  Pr(Y (0) = 1)
Relative Risk (RR) rrFP =
Y¯ (1)
Y¯ (0)
rrSP = ESP [rrFP ] ⇡ Pr(Y (1)=1)Pr(Y (0)=1)
Odds Ratio (OR) !FP =
Y¯ (1)
1 Y¯ (1)
Y¯ (0)
1 Y¯ (0)
!SP = ESP [!FP ] ⇡ Pr(Y (1)=1)Pr(Y (1)=0)
.
Pr(Y (0)=1)
Pr(Y (0)=0)
Estimands can be extended so as to incorporate covariate information. For exam-
ple, an analyst may be interested in the risk di↵erence for all males in the population
cohort,
⌧males =
1
N
X
i: unit i is a male
⇣
Yi(1)  Yi(0)
⌘
,
or in the e↵ect of a drug for those units who were exposed to it:
⌧treated =
1
N
X
i:Wi=1
⇣
Yi(1)  Yi(0)
⌘
.
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1.2.5 Two mechanisms create missing data, or not
Two mechanisms create missing data, or not; one via assignment of each unit to
one of the two possible treatment regimes, the other via sampling or non-sampling of
units into the sample cohort. We call these two mechanisms the assignment mecha-
nism and the realized sampling mechanism, respectively.
Notation
To reflect the existence of two stages of missing data generation, we introduce
double-superscript notation inspired by that in Rubin (1987). Under this notation,
and when applicable5, the first superscript indicates whether a given unit’s mea-
surement or variable (e.g., potential outcome) is realized or missing as a result of
the assignment mechanism, and the second superscript indicates whether the unit in
question is included in, or excluded from, the sample cohort.
We define this notation in Table 1.2 below, where Y denotes a dummy variable
associated with unit i in the population cohort.
5See below for examples of non-applicability.
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Table 1.2: Notation.
Y denotes a dummy variable associated with unit i in the population cohort.
Notation Definition
Y r, ·i realized (irrespective of inclusion or not in the cohort sample)
Y mis, ·i missing (irrespective of inclusion or not in the cohort sample)
Y r, inci realized and included in the sample cohort
Y r, exci realized and excluded from the sample cohort
Y mis, inci missing and included in the sample cohort
Y mis, exci missing and excluded from the sample cohort
Y ·, inci always-realized (by default) and included in the sample cohort
Y ·, exci always-realized (by default) and excluded from the sample cohort
Accordingly, we let Y r, ·i and Y
mis, ·
i denote, respectively, the realized and missing
potential outcome of each unit i in the population cohort. By definition:
Y r, ·i = WiYi(1) + (1 Wi)Yi(0) (1.2)
Y mis, ·i = (1 Wi)Yi(1) +WiYi(0) (1.3)
Likewise, associated with each unit i are one realized, and one missing, potential
sampling indicator, which we denote by Sr, ·i and S
mis, ·
i , respectively. By definition,
and under SUTVA-S:
Sr, ·i = WiSi(1) + (1 Wi)Si(0) (1.4)
Smis, ·i = (1 Wi)Si(1) +WiSi(0) (1.5)
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For example, Sr, ·7 = 1 would denote inclusion of unit 7 in the cohort sample under
treatment received by unit 7. Note that, by default, the treatment assignment and
covariate variables are “always-realized” in that they do not have missing potential
counterparts the way potential outcomes and potential sampling indicators do. As
such, we let x·, inci and x
·, exc
i denote, respectively, the (always-realized and) included,
and (always-realized and) excluded covariate vectors for unit i. Namely,
x·, inci = xi if S
r, ·
i = 1 (1.6)
and x·, exci is missing data when S
r, ·
i = 0. Similarly, we let W
·, inc
i and W
·, exc
i denote,
respectively, the (always-realized and) included, and (always-realized and) excluded
assignment for unit i. Hence,
W ·, inci = Wi if S
r, ·
i = 1 (1.7)
and W ·, exci is missing data when S
r, ·
i = 0. Finally, we let Y
r, inc
i and Y
mis, inc
i de-
note, respectively, unit i’s realized and included, and missing and included potential
outcome. That is,
Y r, inci = Y
r, ·
i if S
r, ·
i = 1 (1.8)
Y mis, inci = Y
mis, ·
i if S
r, ·
i = 1 (1.9)
Variables Y r, exci and Y
mis, exc
i are excluded, and therefore constitute missing data.
Note that these variables are non-identifiable without unit i’s treatment assignment
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information.
Unit-level notation introduced in this section readily extends to vectors, and ma-
trices when applicable.
The assignment mechanism
The first missing data mechanism, previously discussed in Section 1.1.3, is the
assignment mechanism. One of the three central components of the RCM, the as-
signment mechanism is the process that governs which population cohort units are
exposed to the active treatment, and which are exposed to the control treatment.
Formally, it is defined (see Rubin, 1975; Imbens and Rubin, 2015) as a “function
that assigns probabilities to all 2N possible N vectors of assignments W , given the
N vectors of potential outcomes Y (0) and Y (1), and given the N ⇥ K matrix of
covariates X:
Definition 1 (Assignment Mechanism). The assignment mechanism is a row-
exchangeable function Pr(W |W ,Y (0),Y (1)), taking on values in [0, 1], satisfying
X
W2{0,1}N
Pr(W |X,Y (0),Y (1)) = 1, (1.10)
for all X,Y (0), and Y (1).”
We refer the reader to Imbens and Rubin (2015) for additional discussion and
examples.
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The potential sampling mechanism
As its name suggests, the potential sampling mechanism is the process that governs
sampling or non-sampling of population cohort units under both treatment regimes.
Formally, we define it as a function that assigns probabilities to all 2N ⇥ 2N possible
pairs of N vectors of potential sampling indicators, given the N vectors of potential
outcomes Y (0) and Y (1), the N⇥K matrix of covariatesX, and given the N vector
of treatment assignmentsW :
Definition 2 (Potential Sampling Mechanism). Given a population cohort of
N units, the potential sampling mechanism is a row-exchangeable function
Pr(S(0),S(1)|W ,X,Y (0),Y (1)), taking on values in [0, 1], satisfying
X
S(0)2{0,1}N , S(1)2{0,1}N
Pr(S(0),S(1)|W ,X,Y (0),Y (1)) = 1, (1.11)
for allW ,X,Y (0), and Y (1).
Note that the potential sampling mechanism applies to both potential sampling
indicator vectors despite it being impossible, by the fundamental problem of causal
inference, to observe both indicators simultaneously for any given unit. This attribute
makes it a hypothetical construct: under our case-noncase setup, for instance, whether
any given unit would have been sampled under the treatment alternative to the one
actually received6 has no direct bearing on the (non-)inclusion of said unit in the
cohort sample. Notwithstanding, we introduce the potential sampling mechanism as
above for three main reasons.
6We assume treatment compliance and thereby use “assigned” and “received” interchangeably.
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The first is pedagogical and expository. The potential sampling mechanism al-
lows investigators to contemplate the occurrence (and to quantify the probability) of
unit sampling under both treatment regimes: “Had she been exposed to the alterna-
tive treatment, would unit 5 have been selected into the sample cohort? If so, with
what probability?”. The mechanism, as such, elucidates the complex relationship
between the sample cohort and the population cohort. What’s more, we believe that,
much in the same way that potential outcomes, in conjunction with the assignment
mechanism, make explicit the very nature — and challenges — of causal inference
(e.g., it being a missing data problem, where missingness is governed by the assign-
ment mechanism), potential sampling indicators, in conjunction with the potential
sampling mechanism, reveal the conceptually subtle nature of the causal inference
problem for retrospective designs.
The second reason is that of generality. The potential sampling mechanism defined
as above encompasses a large class of retrospective designs. Though fictional, a study
design under which sampling of any given unit under any given treatment depends
on that unit’s missing potential outcome can be formally defined under our setup.
Lastly, the potential sampling mechanism serves as a natural building block for
the realized sampling mechanism, which we define next.
The realized sampling mechanism
The realized sampling mechanism is the process that governs which population
cohort units are selected into the sample cohort, and which are not. Formally, we
define it as a function that assigns probabilities to all 2N possible realized sampling
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vectors Sr, ·, given the N vectors of potential outcomes Y (0) and Y (1), the N ⇥K
matrix of covariates X, and given the N vector of treatment assignmentsW :
Definition 3 (Realized Sampling Mechanism). Given a population cohort of
N units, the realized sampling mechanism is a row-exchangeable function
Pr(Sr, ·|W ,X,Y (0),Y (1)), taking on values in [0, 1], satisfying
X
Sr, ·2{0,1}N
Pr(Sr, ·|W ,X,Y (0),Y (1)) = 1, (1.12)
for allW ,X,Y (0), and Y (1).
Properties of the realized sampling mechanism
Imbens and Rubin (2015) discuss “three general properties that assignment mech-
anisms may satisfy”: individualisticness, probabilisticness, and unconfoundedness.
Below, we define analogues of said properties for the realized sampling mechanism.
We then assess whether these properties hold under the case-noncase setup outlined
in Section 1.1.1; namely, under sampling of all realized population cohort cases, and
simple random sampling with known probability ⇡ > 0 of realized population cohort
noncases.
(i) Individualisticness
Definition 4 (Individualistic realized sampling mechanism). A realized sam-
pling mechanism is individualistic if the realized sampling probability of any particu-
lar population cohort unit is only a function of that unit’s assignment, covariate, and
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potential outcome values.
Proposition 1 (Individualisticness of realized sampling mechanism). The
realized sampling mechanism is individualistic.
Proof. The proposition follows immediately from the fact that, independently for
i = 1, · · · , N ,
Sr, ·i
d
=Y r, ·i +B(1  Y r, ·i ) (1.13)
where B ⇠ Bern(⇡) is independent of Y r,·i .
⌅
(ii) Probabilisticness
Definition 5 (Probabilistic realized sampling mechanism). A realized sam-
pling mechanism is probabilistic if the realized sampling probability is strictly between
zero and one for every unit in the population cohort. That is, every unit has the possi-
bility of being selected into the sample cohort and the possibility of not being selected
into the sample cohort.
Proposition 2 (Probabilisticness of realized sampling mechanism). The
realized sampling mechanism is not probabilistic.
Proof. The proposition follows from noting that, for those units for which Y r, ·i = 1,
Pr(Sr, ·i = 1|Wi, Xi, Yi(0), Yi(1)) = 1. (1.14)
⌅
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(iii) Unconfoundedness
Definition 6 (Unconfounded realized sampling mechanism). A realized sam-
pling mechanism is unconfounded if it does not depend on the potential outcomes:
Pr(Sr, ·|W ,X,Y (0),Y (1)) = Pr(Sr, ·|W ,X,Y 0(0),Y 0(1)), (1.15)
for allW ,X,Y (0),Y (1),Y 0(0), and Y 0(1).
Proposition 3 (Confoundedness and ignorability of realized sampling
mechanism). The realized sampling mechanism is confounded, but ignorable (Little
and Rubin, 2002) in that it can be written as a function of W, X and Yr, · only,
without dependence on Ymis,·.
Proof. See Proposition 1 proof. ⌅
Corollary 1 (Ignorability of realized sampling mechanism for Bayesian
inference). Under the conditions of Proposition 3, and assuming a priori inde-
pendence between the parameters of the distributions of Sr, ·i and Y
r, ·
i , the realized
sampling mechanism is ignorable for Bayesian inference, as defined in Little and Ru-
bin (2002).
We refer the reader to Little and Rubin (2002) for an in-depth discussion of
ignorability. A key implication and benefit of an ignorable missing data mechanism
is that it allows Bayesian inference to be based on the observed data likelihood only:
the missing data mechanism, as the name suggests, can be ignored. Conveniently,
the realized sampling mechanism is ignorable. However, it is also confounded.
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Consider equation 1.13 above. By definition, for those units i in the sample cohort,
Sr, ·i = 1. By (1.13), therefore,
1 = Sr, ·i (1.16)
d
= Y r, ·i +B(1  Y r, ·i ) (1.17)
= WiYi(1) + (1 Wi)Yi(0) +B(1  [WiYi(1) + (1 Wi)Yi(0)]). (1.18)
This illustrates that confoundedness of the realized sampling mechanism induces dis-
tributional dependence between treatment assignments and (realized) potential out-
comes in the sample cohort. In other words, the “sample cohort assignment mecha-
nism” (i.e., the population cohort assignment mechanism, restricted to sample cohort
units) is generally not unconfounded:
Pr(W ⇤|X⇤,Y ⇤(0),Y ⇤(1)) 6= Pr(W ⇤|X⇤) (1.19)
where for given variable Z, Z⇤ := Z|i:Sr, ·i =1. (Potential outcomes cannot be dropped
from the right-hand side of the equation, trivially because of the definition of starred
variables). This invalidates the use of matched sampling methods on sample cohort
data for purposes of pretreatment bias reduction in the estimation of population cohort
causal e↵ects.
1.2.6 Sample cohort: observed data
Ultimately, data that is observed by the analyst consists of (always-)realized vari-
ables for those units in the sample cohort. Specifically, observed data consists of (a)
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the vector of realized sampling indicators, Sr, ·, (b) the vector of realized and included
potential outcomes, Y r, inc, (c) the vector of included assignments ,W ·, inc and lastly
(d) the matrix of included covariates, X ·, inc. We represent these variables jointly by
the observed data matrix Y˜
obs
:
Y˜
obs
= (Sr, ·,Y r, inc,W ·, inc,X ·, inc) (1.20)
Henceforth, we shall refer to this set of observed data as case-noncase data, realized
sample cohort data, or simply as sample cohort data.
Conversely, missing data consists of (a) the vector of missing and included po-
tential outcomes Y mis, inc, (b) the vector of missing and excluded potential outcomes
Y mis, exc, (c) the vector of excluded assignments, W ·, exc and (d) the matrix of ex-
cluded covariates, X ·, exc. We represent these variables jointly by the missing data
matrix Y˜
mis
:
Y˜
mis
= (Y mis, inc,Y r, exc,W ·, exc,X ·, exc) (1.21)
Note that we omit Smis, · which, although important for conceptual understanding,
plays no role in either missing data mechanism. Also note that under the assumption
of sampling of all cases, Y r, exc is known to be 0.
1.2.7 Sample cohort data generation, summarized
Sample cohort data generation can be compactly summarized in the form of Table
1.3 below. In this toy example, the population cohort consists of 24 units. Assumed
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is sampling of all cases, and simple random sampling of noncases with sampling
probability ⇡ = 0.5. (Note that this sampling rate would generally be significantly
lower in real-life studies.) As such, Yi(w) = 1 implies Si(w) = 1 for w 2 {0, 1},
and all i 2 1, · · · , 24. Bolded vectors refer to variables introduced throughout this
section. Columns 2 to 5, in dark gray, represent observed data. Columns 7-12, in
light gray, represent complete data. (In particular, columns 10-12 are what Rubin
commonly refers to as “the science”; i.e. data which, if observed, would allow the
analyst to directly calculate the causal estimand of her choosing.) Lastly, column
6, which consists of the vector Yr, ·, represents partially observed data. When read
from right to left, the table illustrates sample cohort data generation, starting from
the population cohort.
1.2.8 Additional terminology
We introduce additional terminology for purposes of expository clarity in Section
2.1 (see, in particular, Section 2.1.2 discussion), and clarity in Chapter 3. We define
the complete population cohort dataset as the dataset consisting of population cohort
covariates, potential outcomes, and treatment assignments. We define the realized
population cohort dataset as the dataset consisting of population cohort covariates,
realized potential outcomes, and treatment assignments.
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Table 1.3: Sample cohort data generation: a toy example with N = 24 population
cohort units. All cases are sampled with probability 1; noncases are sampled via simple
random sampling with probability ⇡ = 0.5. As such, Yi(w) = 1 implies Si(w) = 1 for
w 2 {0, 1}, and all i 2 1, · · · , 24.
Unit Y r, inc W ·, inc X ·, inc Sr, · Y r, · S(0) S(1) W Y (0) Y (1) X
1 1 0 x1 1 1 1 1 0 1 0 x1
2 1 0 x2 1 1 1 1 0 1 1 x2
3 1 0 x3 1 1 1 0 0 1 0 x3
4 1 0 x4 1 1 1 1 0 1 1 x4
5 1 1 x5 1 1 1 1 1 1 1 x5
6 1 1 x6 1 1 1 1 1 1 1 x6
7 1 1 x7 1 1 1 1 1 1 1 x7
8 1 1 x8 1 1 1 1 1 1 1 x8
9 0 0 x9 1 0 1 1 0 0 0 x9
10 0 0 x10 1 0 1 0 0 0 0 x10
11 0 0 x11 1 0 1 1 0 0 0 x11
12 0 0 x12 1 0 1 0 0 0 0 x12
13 0 0 0 1 0 0 0 x13
14 0 0 0 0 0 0 0 x14
15 0 0 0 1 0 0 0 x15
16 0 0 0 0 0 0 0 x16
17 0 1 x17 1 0 0 1 1 0 0 x17
18 0 1 x18 1 0 1 1 1 0 0 x18
19 0 1 x19 1 0 0 1 1 0 0 x19
20 0 1 x20 1 0 1 1 1 0 0 x20
21 0 0 1 0 1 0 0 x21
22 0 0 0 0 1 0 0 x22
23 0 0 1 0 1 1 0 x23
24 0 0 1 0 1 1 0 x24
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1.2.9 On retrospective matching
As an immediate application of the framework thus introduced, we discuss the
tangential topic of retrospective matching in case-noncase studies, from the causal
inference perspective. Following Holland and Rubin (1988), let ‘prospective matching’
be understood as matching in the sense of Rubin (2005b); namely, the matching of
control treatment units to active treatment units, onX. Let retrospective matching7
be understood as the “pairing of one or several noncases to each case, on the basis of
their similarity with respect to selected variables” (Schlesselman, 1982).
Retrospective matching is used for noncase sampling in the ‘matched case-noncase’
study design. It is a popular practice in applied epidemiological research: 46.4% of
case-noncase studies published in 1994 were of the matched type (Gefeller et al.,
1998). In spite of its popularity, retrospective matching has long been the subject of
controversy. For instance, according to a literature review by Rose and van der Laan
(2009b), many early texts described the method as a way to reduce ‘confounding’,
which Schlesselman defines as “the e↵ect of an extraneous variable that wholly or
partially accounts for the apparent e↵ect of the study exposure, or that masks an
underlying true association” (see, e.g., Schlesselman, 1982; Miettinen, 1970; Breslow
and Powers, 1978; Breslow and Day, 1980). The more recent articles, however, have
argued otherwise (see, e.g. Costanza, 1995; Rothman et al., 2008; Rose and van der
Laan, 2009b).
Of note, Schlesselman (1982) writes that “the primary objective of matching is
7The term was coined by Holland and Rubin (1988), and is typically simply referred to as
‘matching’ in the epidemiological literature.
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the elimination of biased comparisons between cases and [noncases ]”. Our position
is that matching, on the contrary, should be used to ensure unbiased comparison
between control treatment units and active treatment units. Prospective matching
achieves the latter purpose by reconstructing the blocked randomized design within
an observational dataset (Rubin, 2005b). That is, it creates balance in covariate
distributions between the two treatment subgroups. Retrospective matching, as we
now show, generally does not. Let us consider the example case-noncase datasets
represented in Tables 1.4 and 1.5 below. Also, let us assume, for the sake of argument,
unconfoundedness of the assignment mechanism in the presence of covariate sex.
By construction of dataset 1, exact retrospective matching is feasible — i.e, every
case can be matched to a noncase based on sex. However, it is impossible for the
investigator to learn about the treatment e↵ect via prospective matching, because
treatment assignment and sex are perfectly correlated. This shows that retrospective
matching does not, generally, ensure comparability between control treatment and
active treatement units.
Conversely, in example 2, exact prospective matching is possible — i.e., every
control unit can be matched to an active unit based on sex — whereas retrospective
matching is not — i.e., realized potential outcomes and sex are perfectly correlated.
This suggests that retrospective matching can misguide the investigator into discard-
ing data that is (highly) informative of the treatment e↵ect.
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Table 1.4: Retrospective matching,
example 1.
‘?’ denotes a missing potential outcome.
‘M’ stands for male; ‘F’ for female.
Retrospective matching is possible.
Can’t learn about treatment e↵ect,
even assuming unconfounded A.M.
Unit Y (0) Y (1) W Y r, · sex
1 1 ? 0 1 M
2 1 ? 0 1 M
3 0 ? 0 0 M
4 0 ? 0 0 M
5 ? 1 1 1 F
6 ? 1 1 1 F
7 ? 0 1 0 F
8 ? 0 1 0 F
Table 1.5: Retrospective matching,
example 2.
‘?’ denotes a missing potential outcome.
‘M’ stands for male; ‘F’ for female.
Retrospective matching is impossible.
Can learn about treatment e↵ect,
assuming unconfounded A.M.
Unit Y (0) Y (1) W Y r, · sex
1 1 ? 0 1 M
2 1 ? 0 1 M
3 ? 1 1 1 M
4 ? 1 1 1 M
5 0 ? 0 0 F
6 0 ? 0 0 F
7 ? 0 1 0 F
8 ? 0 1 0 F
Another disadvantage of the use of retrospective matching is the potential for
population cohort definition complication, or ill-definedness.
1.3 Discussion
To conclude, the causal inference framework introduced in this chapter extends
the many benefits of the Rubin Causal Model to retrospective studies. Through for-
mulation of the case-noncase study as a cohort study with missing data, our approach
fills a conceptual gap between (observational) prospective cohort studies and retro-
spective studies. Conceptual coherence ensues: a case-noncase study is a partially
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observed cohort study, which itself is a broken stratified randomized experiment. The
problem of causal inference for retrospective studies is therefore conceptually identical
to that for cohort studies: the challenge is to reconstruct, to the extent possible, the
broken randomized experiment.
In our view, our approach provides a deeper understanding of the case-noncase
study design and related causal inference problem, than do traditional methodologies.
For instance, the classical two-way table (Table 1.3) is typically used to summarize a
case-noncase study, but generally provides no causal insight, as discussed in Holland
and Rubin (1988). By contrast, our data generating mechanism table (Table 1.3)
makes explicit (a) the relationship between the population cohort and sample cohort,
and (b) the missing-data nature of the causal inference problem.
Moreover, as shown in Section 1.2.9, the potential outcomes perspective can shed
new light on an age-old controversy.
Advantages of our framework are further discussed in Chapter 4.
Table 1.6: Table of counts based on n+1 cases and n+0 noncases.
Noncases (Y = 0) Cases (Y = 1) Total
Control (W = 0) nc0 nc1 nc+
Treated (W = 1) nt0 nt1 nt+
Total n+0 n+1 n++
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PrepDA for objective causal
inference
2.1 PrepDA: preprocessing, design and analysis of
case-noncase study data for objective causal
inference
2.1.1 Introducing PrepDA
As stated in Section 1.2.5, because of the realized sampling mechanism’s con-
foundedness, and the thereby induced relationship between treatment assignments
and (realized) potential outcomes in the sample cohort, it is invalid to use matched
sampling methods (such as Mahalanobis metric matching) on sample cohort data for
purposes of pretreatment bias reduction in the estimation of population cohort causal
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e↵ects. As previously noted by Ma˚nsson et al. (2007), for instance, subclassification
by propensity score estimates from all population cohort cases and a simple random
sample of the noncases “should give consistent estimates of the true propensity score
under the null hypothesis, but not otherwise”. While one could analytically adjust
sample cohort-based estimates of the population cohort propensity score by account-
ing for the implicit conditioning on {Sr, · = 1}, such approach would violate Rubin’s
principle of outcome-free design for causal e↵ect estimation.
Instead, we propose a methodology that both circumvents the above confounded-
ness-related problem and adheres to Rubin’s principles of objective design. The pro-
cedure, which we call by the acronym “PrepDA” for Preprocessing Design Analysis,
stochastically recreates, via multiple imputation, a set of realized population cohort
datasets from realized sample cohort data. Each such simulated dataset constitutes
a prospective observational study, to which Rubin’s outcome-free design and analysis
procedures are then applied. This enables objective estimation of causal e↵ects from
case-noncase data via outcome-free matching or subclassification, post-data prepro-
cessing. By preprocessing, we mean all contemplating, collecting, organizing, model-
ing, and imputation of data.
PrepDA relies on the existence of two parties, say ‘A’ and ‘B’, that operate inde-
pendently from one another. For example, both parties could be research statisticians.
In another example, party A would consist of a team of pharmaceutical biostatisti-
cians and party B of independent statistical consultants.
Our methodology can be compactly summarized by the following three steps:
1. [preprocessing ] Using sample cohort data, Party A multiply imputes, under
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some statistical model, missing covariate, potential outcome, and treatment as-
signment data for the entire population cohort, thereby generatingM simulated
complete population cohort datasets. Party A then strips outcome data from
each of the M imputed datasets. (Information regarding steps 2-4 is at this
stage withheld from Party A. Party B is assumed not to be involved in this first
step.)
Table 2.1 below depicts one such imputed dataset, starting hypothetically from Table
1.3 data.
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Table 2.1: Example of singly imputed com-
plete population cohort dataset, obtained by
implementing step 1 of PrepDA using ob-
served data from Table 1.3.
Imputed data appear in red, italicized.
Unit W Y (0) Y (1) X
1 0 1 (0) x1
2 0 1 (1) x2
3 0 1 (0) x3
4 0 1 (0) x4
5 1 (1) 1 x5
6 1 (1) 1 x6
7 1 (1) 1 x7
8 1 (1) 1 x8
9 0 0 (0) x9
10 0 0 (0) x10
11 0 0 (0) x11
12 0 0 (0) x12
13 (1) (0) (0) (x13)
14 (1) (1) (0) (x14)
15 (0) (0) (0) (x15)
16 (1) (0) (0) (x16)
17 1 (0) 0 x17
18 1 (0) 0 x18
19 1 (1) 0 x19
20 1 (0) 0 x20
21 (1) (0) (0) (x21)
22 (1) (0) (0) (x22)
23 (1) (1) (0) (x23)
24 (0) (0) (0) (x24)
Table 2.2: Table 2.1 dataset, with
outcomes suppressed.
Unit W X
1 0 x1
2 0 x2
3 0 x3
4 0 x4
5 1 x5
6 1 x6
7 1 x7
8 1 x8
9 0 x9
10 0 x10
11 0 x11
12 0 x12
13 (1) (x13)
14 (1) (x14)
15 (0) (x15)
16 (1) (x16)
17 1 x17
18 1 x18
19 1 x19
20 1 x20
21 (1) (x21)
22 (1) (x22)
23 (1) (x23)
24 (0) (x24)
37
Chapter 2: PrepDA for objective causal inference
2. [design ] Party A turns over the M outcome-free imputed datasets to Party B
which, in turn, designs each one of the datasets. Design may involve, but is not
limited to, data trimming, matching or subclassification, and covariate balance
assessment (see, for example, Rubin, 2006, 2008; Imbens and Rubin, 2015).
In our running example, the outcome-free dataset from Table 2.1 above would be
turned over to party B.
3. [analysis] Once Party B’s design phase is finalized, Party A hands over to
party B realized outcome data from each of the M imputed datasets from step
1. Party B then analyzes each of the M imputed and matched or subclassified
realized population cohort datasets according to a strict pre-specified protocol,
and combines theM (sets of) results using Rubin’s rules for Multiple Imputation
(Rubin, 1987).
Table 2.3 below depicts the data that would be analyzed by Party B in this third
step of PrepDA.
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Table 2.3: Table 2.2 dataset, with singly imputed realized potential outcomes Y r, ·
from Table 2.1 appended. (Or, equivalently, singly imputed realized population cohort
dataset.)
Unit Y r, · W X
1 1 0 x1
2 1 0 x2
3 1 0 x3
4 1 0 x4
5 1 1 x5
6 1 1 x6
7 1 1 x7
8 1 1 x8
9 0 0 x9
10 0 0 x10
11 0 0 x11
12 0 0 x12
13 (0) (1) (x13)
14 (0) (1) (x14)
15 (0) (0) (x15)
16 (0) (1) (x16)
17 0 1 x17
18 0 1 x18
19 0 1 x19
20 0 1 x20
21 (0) (1) (x21)
22 (0) (1) (x22)
23 (0) (1) (x23)
24 (0) (0) (x24)
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2.1.2 Discussion
A parallel with prospective cohort and randomized studies
Note that the preprocessing step yields a stochastically generated approximation
of the case-noncase study’s underlying prospective cohort study. This approach ex-
tends Rubin’s (2007) proposal that prospective observational studies approximate
randomized experiments as closely as possible.
The importance of a two-party procedure
By design, PrepDA relies on two independent parties, where the first is exclusively
responsible for the preprocessing step, and the second for the design and analysis
steps. In particular, Party A should neither be aware of (i.e., is blinded to) party
B’s design and analysis protocols, nor the study’s causal objectives. To insure this,
information regarding steps 2-4 is withheld from Party A at the time of step 1 im-
plementation. The purpose of this separation is to minimize, to the extent possible,
analyst bias in causal e↵ect estimation. It prevents, in particular, any given analyst
from preprocessing cohort data in a manner that (could) deliberately impact(s) the
study’s overall findings. An example of such intentional manipulation is the fit of
various imputation models via trial and error, with knowledge of subsequent design
schemes and analysis protocols. We illustrate this idea in Section 2.1.2 below.
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The design and analysis, post-preprocessing, of realized versus complete
imputed population cohort datasets
To be clear, in the third step of the procedure, party B analyzes realized, not
complete, multiply imputed population cohort datasets. This serves two purposes.
The first is to recreate the analysis that would have been performed on the prospective
realized population cohort datasets, had that data been available to the investigator
— see Section 2.1.2 comment above. The second is to prevent the methodology from
being solely dependent on Party A’s imputation model: party B, in fact, imputes
missing (population cohort) potential outcome data in the analysis step of PrepDA.
Note that correct coverage of our procedure relies on having congeniality of the
imputation and analysis models (see Meng, 1977). In practice, this should not be of
major concern, unless models used by party A and party B have major inconsistencies.
In addition, the use of matching or subclassification methods in the design phase of
PrepDA, which limits reliance on model assumptions in the analysis step of PrepDA,
mitigates such risk. Also note that Party B’s analysis step may be redundant if the
imputer’s (Party A’s) model accurately estimates missing potential outcome data.
This, in turn, may result in the introduction of noise in the overall estimation of causal
e↵ects. We nonetheless believe that the added benefit of investigator objectivity,
which PrepDA guarantees, outweighs the risk of possible addition of analytical bias
and/or variance.
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Towards a new notion of covariate balance
PrepDA requires a new notion of covariate balance between active treatment and
control treatment groups. Because the causal e↵ect is estimated by combining esti-
mates obtained from M imputed datasets, there is a need to develop metrics that
adequately summarize balance over multiple datasets. This topic is postponed to
Chapter 3 of this thesis. An example of metric that comes immediately to mind is
the average standardized distance between active treatment and control treatment
covariate distributions, where the average is taken over the M imputed datasets.
A litigation example
Consider the scenario in which a pharmaceutical company is facing a class-action
lawsuit alleging one of its drugs, say ‘D’, causes birth defects. Suppose, further, that
evidence presented to the court includes a case-noncase dataset, which the plainti↵s’
experts analyzed using logistic regression, and concluded a statistically significant
association between intake of drug D and birth defects.
Now suppose that company’s counsel engages two independent statistical consul-
tants, ‘A’ and ‘B’, to analyze the dataset using PrepDA. Following consultant A’s
implementation of the preprocessing step, and upon consultant B’s review of the M
simulated outcome-free population cohort datasets, consultant B opines that there is
not enough overlap in the distributions of key covariates between individuals who took
drug D and those who did not take the drug, to conclude existence, or non-existence,
of a causal e↵ect of taking drug D on birth defects — the analysis, according to her,
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is inconclusive.
The above example illustrates a powerful application of PrepDA in the litigation
setting. In contrast to plainti↵s’ expert, analyst B could not have seen the litigation
answer before making any assessments regarding adequacy of data and/or analysis
methodology. Reliance on PrepDA, as such, protects her from accusations of delib-
erate data manipulation or subjective analysis, and thereby accords plausibility to
her findings. We refer the reader to Kousser (1984) and Greiner (2008) for further
discussion of the (mis)use of logistic regression in the litigation and academic set-
tings. Another related reference is Robertson (2010), which discusses blind expertise
in litigation.
Conclusion
To conclude, PrepDA shares the many advantages of Rubin’s methodologies for
causal inference (see Imbens and Rubin, 2015). Among other, PrepDA (a) allows
for outcome-free matching or subclassification for pre-treatment bias reduction, post-
preprocessing, (b) prevents researchers from running multiple (regression) models on
observed data, and ultimately choosing the one result that is most in line with their
research agenda, and (c) forces investigators to assess the validity of their causal
findings by checking for overlap in covariate distributions between treatment groups,
also post-preprocessing. We further discuss these advantages in Chapter 4.
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2.2 Simulation study: estimation of ⌧FP and !FP
from case-noncase data, assuming presence of
one covariate only
In this section we illustrate the application of PrepDA in a simple non-trivial
setting that assumes the presence of one covariate only; i.e., XN⇥k = XN⇥1. We
investigate our methodology’s operating characteristics via simulation under various
conditions, and compare them to those of logistic and probit regression when ap-
plicable. The problem addressed throughout this section is that of causal inference
with case-noncase data, where estimands of interest are the population cohort risk
di↵erence, ⌧FP = Y¯ (1)  Y¯ (0), and the population cohort odds ratio, !FP =
Y¯ (1)
1 Y¯ (1)
Y¯ (0)
1 Y¯ (0)
.
Naturally, we work under the framework introduced in Section 1.2.
2.2.1 A model for population cohort data generation
For each simulation condition (see Section 2.2.4), we generate complete population
cohort data, Y˜
compl
, according to the following model. Let µ0, µ1 2 R and p 2 (0, 1).
Marginally, the assignment of each unit i is modeled independently with a Bernoulli(p)
distribution:
Wi|p ⇠ Bern(p). (2.1)
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For each i, independently and conditionally on treatment receivedWi, we let covariate
Xi follow a Normal distribution with mean µWi and variance  
2
Wi
:
Xi|Wi, µWi , Wi ⇠ N (µWi , 2Wi). (2.2)
Specifications 2.1 and 2.2 induce the following assignment mechanism:
Pr(Wi = w|Xi, µ0, µ1, 0, 1, p) = p
w(1  p)(1 w) ·  (Xi;µw, 2w)
(1  p) ·  (Xi;µ0, 20) + p ·  (Xi;µ1, 21)
, (2.3)
for w 2 {0, 1}. Next, let  (j)0 ,  (j)X 2 R for j 2 {0, 1}. For all i, and given covari-
ates Xi, potential outcomes Yi(0) and Yi(1) are modeled independently according to
generalized linear models:
Pr(Yi(0) = 1|Xi,  (0)0 ,  (0)X ) = F ( (0)0 +  (0)X Xi), and (2.4)
Pr(Yi(1) = 1|Xi,  (1)0 ,  (1)X ) = F ( (1)0 +  (1)X Xi), (2.5)
where F (·) is the c.d.f. of a specified distribution, and F 1(·) is the link function.
For purposes of this study, we consider the logit and probit links; see Section 2.2.4
for more details.
Finally, let ⇡ 2 (0, 1) fixed. We specify unit-level potential sampling probabilities
Pr(Si(0), Si(1)|Wi, Xi, Yi(0), Yi(1), ⇡)
independently for each unit i. We set (Si(0), Si(1)) to be conditionally independent
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of Wi and Xi (and  
(0)
0 ,  
(0)
X ,  
(1)
0 , and  
(1)
X ) given Yi(0), Yi(1) and ⇡:
Pr(Si(0), Si(1)|Wi, Xi, Yi(0), Yi(1), ⇡) = Pr(Si(0), Si(1)|Yi(0), Yi(1), ⇡) (2.6)
Because sampling under control (active) treatment solely depends on unit i’s potential
outcome under control (active) treatment,
Pr(Si(0), Si(1)|Wi, Xi, Yi(0), Yi(1), ⇡) = Pr(Si(0)|Yi(0), ⇡) · Pr(Si(1)|Yi(1), ⇡). (2.7)
Together with the assumptions of sampling of all cases, and simple random sampling
with known probability ⇡ of noncases, this yields:
Pr(Si(0) = si0, Si(1) = si1|⇢⇢Wi,⇢⇢Xi, Yi(0), Yi(1), ⇡) =
 
⇡si0(1  ⇡)(1 si0) 1 Yi(0)
⇥  ⇡si1(1  ⇡)(1 si1) 1 Yi(1) . (2.8)
We represent the set of parameters from the above model by ✓:
✓ = (p, µ0, 0, µ1, 1,  
(0)
0 ,  
(0)
X ,  
(1)
0 ,  
(1)
X )
0
. (2.9)
2.2.2 Sample cohort data generation
For each simulation condition and generated complete cohort dataset Y˜
compl
, we
obtain Y˜
obs
via simple application of Section 1.2.5 definitions.
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2.2.3 Two methods of analysis: PrepDA and regression ad-
justment
To each generated sample cohort dataset, we apply PrepDA and regression, as
follows.
PrepDA
Given the computational intensity of our simulations, we implement an automated
version of PrepDA. Practical demonstration of PrepDA’s objectivity and its contrast
to regression methods is postponed to Chapter 3.
1. [preprocessing ] We generate M = 100 imputed population cohort datasets
using Bayesian iterative simulation methods. We assume the generative model
from Section 2.2.1 with probit link function F 1(·) ⌘   1(·)1. The following
observed log-likelihood ensues:
1The probit link provides a convenient Gibbs sampler and closed-form analytical results.
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`(✓|Y˜ obs) =
X
i:Sr, ·i =1
(
W ·, inci Y
r, inc
i log[ ( 
(1)
0 +  
(1)
X X
·, inc
i )]
+W ·, inci (1  Y r, inci )log[1   ( (1)0 +  (1)X X ·, inci )]
+ (1 W ·, inci )Y r, inci log[ ( (0)0 +  (0)X X ·, inci )]
+ (1 W ·, inci )(1  Y r, inci )log[1   ( (0)0 +  (0)X X ·, inci )]
+ (1 W ·, inci )log[N(X ·, inci ;µ0, 20)] +W ·, inci log[N(X ·, inci ;µ1, 21)]
+W ·, inci log[p] + (1 W ·, inci )log[1  p]
)
+ (N   ninc)
⇥ log
"
1  (1  p) ·  
(
 (0)0 +  
(0)
X µ0q
1 +  20 
(0)
X
2
)
  p ·  
(
 (1)0 +  
(1)
X µ1q
1 +  21 
(1)
X
2
)#
(2.10)
where ninc :=
P
i S
r, ·
i , ✓ as in (2.9) and Y˜
obs
= (Sr, ·,Y r, inc,W ·, inc,X ·, inc).
Two key steps are repeated to distributionally impute missing data Y˜
mis
. The
first consists of drawing a set of parameters ✓⇤ from the posterior distribution
of the parameters given the observed data, f(✓|Y˜ obs), using MCMC sampling
via RStan software (Stan Development Team, 2014, see Appendix A.3.1 for
further details). Given this draw for the parameters, we substitute the values
✓⇤ into the conditional distribution of Y˜
mis
given Y˜
obs
and ✓⇤, f(Y˜
mis|Y˜ obs,✓⇤),
to impute a set of missing data Y˜
mis
. See Appendix A.3.2 for analytical and
computational specifics involved in this second setup.
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Next, we suppress both potential outcome vectors from each generated complete
population cohort dataset.
2. [design ]We trim each of theM = 100 outcome-free imputed population cohort
datasets. That is, we discard those units in the active treatment arm whose
covariate values do not overlap with the control treatment arm units’ values,
and those units in the control treatment arm whose covariate values do not
overlap with the active treatment arm units’ values. This prevents comparisons
to be made between units that are too dissimilar in X. We then partition the
remaining units into 5 subclasses, S = 1, · · · , 5, using quantiles of X.
3. [analysis] We analyze each of the M imputed realized population cohort
datasets using two procedures, “Neyman Subclassification with Multiple Im-
putation and Trimming” (NSMIT) and “Haldane-Gart Subclassification with
Multiple Imputation and Trimming” (HGSMIT). The first method estimates
the population cohort risk di↵erence, ⌧FP , whereas the second one estimates
the population cohort odds ratio, !FP . NSMIT and HGSMIT are summarized
as follows:
• Neyman Subclassification with Multiple Imputation and Trimming
(NSMIT)
For each trimmed imputed realized population cohort dataset (m), where
m = 1, · · · ,M , we obtain a Neyman point estimate (Neyman, 1923) for
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the risk di↵erence within each of the 5 subclasses S:
⌧ˆ (m)s =
1
Nts
X
i:Wi=1, i2S
Y r,·i  
1
Ncs
X
i:Wi=0, i2S
Y r,·i (2.11)
⌘ ⌧ˆ (m)s,1   ⌧ˆ (m)s,0 , (2.12)
for s 2 {1, · · · , 5}, where Nts =
PN
i=1, i2S Wi and Ncs =
PN
i=1, i2S(1 Wi).
We then obtain an estimate of the variance of ⌧ˆ (m)s :
\
var(⌧ˆ (m)s ) =
⌧ˆ (m)s,1 (1  ⌧ˆ (m)s,1 )
Nts
+
⌧ˆ (m)s,0 (1  ⌧ˆ (m)s,0 )
Ncs
(2.13)
where Ns =
P
i2S 1. (Note that Neyman’s method generates unbiased es-
timates of ⌧FP and generally conservative intervals in large samples (Ney-
man, 1923; Imbens and Rubin, 2015).) Next, we compute the overall
dataset (m)-specific Neyman point estimate, ⌧ˆ (m), by averaging across sub-
classes, weighting according to the number of units in each subclass, and
the corresponding 95% large sample confidence interval.
We combine results from each of the M imputed datasets using Rubin’s
Rules for Multiple Imputation (Rubin, 1987) to get an overall estimate, ⌧¯ ,
of risk di↵erence:
⌧¯ =
1
M
X
m
⌧ˆ (m) (2.14)
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and an estimate, T , of its variance,
T =
✓
1 +
1
M
◆
B + U¯ (2.15)
where B = 1M 1
P
m(⌧ˆ
(m)  ⌧¯)2 and U¯ = 1M
P
m
\Var(⌧ˆ (m)). The confidence
interval for ⌧ is obtained using:
(⌧¯   ⌧)/pT ⇠ t⌫ where ⌫ = (M   1)
h
1 +
⌧¯
(1 +M 1)B
i2
. (2.16)
• Haldane-Gart Subclassification with Multiple Imputation and Trimming
(HGSMIT)
In a similar fashion to NSMIT, for each trimmed simulated realized popu-
lation cohort dataset, we obtain an overall dataset (m)-specific point esti-
mate for the log odds ratio by averaging subclass-specific point estimates.
We then obtain the corresponding 95% interval. We use Haldane’s exten-
sion (Haldane, 1955) of Woolf’s method (Woolf, 1955) to estimate the log
odds ratio within each subclass S:
log(!ˆ(m)s ) = log
h(nt1s + 0.5)(nc0s + 0.5)
(nt0s + 0.5)(n
c1
s + 0.5)
i
, (2.17)
for s 2 {1, · · · , 5}, where nt1s =
PN
i=1, i2S WiY
r,·
i , n
c0
s =
PN
i=1, i2S(1  
Wi)(1 Y r,·i ), nt0s =
PN
i=1, i2S Wi(1 Y r,·i ) and nc1s =
PN
i=1, i2S(1 Wi)Y r,·i .
(An advantage of Haldane’s estimator over Woolf’s is that the former exists
for samples in which nt1s , n
c0
s , n
t0
s or n
c1
s has a null value.) We use Gart’s
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method (Gart, 1966):
log!ˆ ± 1.96
p
1/(nt1s + 0.5) + 1/(n
t0
s + 0.5) + 1/(n
c1
s + 0.5) + 1/(n
c0
s + 0.5)
(2.18)
to compute 95% confidence intervals. (Note that Haldane’s method pro-
duces an approximately unbiased estimate of !FP ; Woolf’s method gen-
erates generally conservative intervals in large samples (Haldane, 1955;
Ding and Dasgupta, 2015).) We ultimately obtain an overall odds ratio
estimate !¯ and corresponding 95% confidence interval via application of
Rubin’s Rules for Multiple Imputation, followed by exponentiation.
(4.) [(preprocessing results)] In addition, we directly calculate the average risk
di↵erences and odds ratios from each of theM imputed complete population co-
hort datasets. This procedure yields M estimates of ⌧ˆFP , T = {⌧ˆ (1), · · · , ⌧ˆ (M)},
and M estimates of !FP , O = {!ˆ(1), · · · .!ˆ(M)}. We obtain overall point esti-
mates and credible intervals for ⌧FP and !FP by taking the mean and (0.25,
0.975) quantiles of M and O, respectively.
We henceforth refer to this method as “Multiple Imputation” (MI).
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Logistic regression (LR) and probit regression (PR)
We fit logistic and probit regression models, where Y r, inc is regressed on W ·, inc
and X ·, inc:
logit[Pr(Y r, inci = 1|Xi)] =  0 +  !W ·, inci +  XX ·, inci (2.19)
  1[Pr(Y r, inci = 1|Xi)] =  0 +  !W ·, inci +  XX ·, inci (2.20)
In both cases, we exponentiate the estimated regression coe cient for W ·, inc to
obtain an estimate !ˆSP |W,X = e ˆ! of !FP . We obtain a corresponding 95% confidence
interval by exponentiating the endpoints of the conventional Normal-based confidence
interval for  ˆ!.
Note that the logistic regression method provides estimates of the conditional, not
marginal, and super, not finite, population odds ratio. Despite this, we implement
it so as to investigate the method’s performance in estimating the causal population
cohort odds ratio, an estimand we believe is of greater interest in many, if not most,
epidemiological studies.
Also note that probit regression is generally not used for purposes of (conditional)
odds ratio inference. We implement it here to investigate the regression methods’
sensitivity to link function F 1(·) misspecification.
2.2.4 Simulation design
We investigate frequentist operating characteristics of PrepDA under various simu-
lation conditions, and assess how logistic and probit regression perform in comparison
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for estimating !FP . Table 2.4 below specifies factors used in our study, which can be
described as a 26 factorial design.
Table 2.4: Simulation factors.
Factor Levels of factor
N {1000}
⇡ {0.1}
p {0.5}
 (0)0 {-3, -2}
 (1)0 {-3, -2}
 (0)X {-1, -12}
 (1)X {-1, -12}
 20 {2}
µ0 {0}
 21 {1}
B = µt µcr
 21+ 
2
0
2
{0, 1}
F (1)(·) {logit(·),  (·)}
In a typical case-cohort study, the two first factors would be known to the investi-
gator, whereas the last ten would be unknown. Simulation parameters were selected
so as to sensibly emulate real-life settings while taking into account the computa-
tionally intensive nature of the study. The latter, in particular, informed our choice
of population cohort size, N . A sampling rate of noncases of ⇡ = 0.1, in conjunc-
tion with chosen levels of N and   :=
 
 (0)0 ,  
(0)
X ,  
(1)
0 ,  
(1)
X
 
ensured generation of
su ciently large sample cohorts for purposes of statistical inference. Factor F 1 in-
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vestigates departure from the probit link, which is assumed in the preprocessing step
of PrepDA. Lastly, as in Cochran and Rubin (1973), we parametrize the distance
between treated and control group covariate means in terms of the standardized bias
B =
µt   µcq
 21+ 
2
0
2
(2.21)
so as to evaluate the factor’s influence independently of the variance ratio  
2
0
 21
. A level
of B=2 was initially considered, but yielded too little overlap in covariate distributions
between treated and control sample cohort units, and was thus withdrawn from the
study.
For every combination of factor levels above, we generate 100 complete population
cohort datasets, as described in Section 2.2.1. From each generated complete popula-
tion cohort dataset, we obtain a sample cohort dataset. For purposes of comparison
with logistic and probit regression methods, data is regenerated if perfect separation
occurs in the fit of either the logistic or probit model. We then perform six di↵erent
analyses: MI and NSMIT to estimate the population cohort risk di↵erence, ⌧FP , and
MI, HGSMIT, LR and PR to estimate the population cohort odds ratio, !FP . Each
method is evaluated based on three criteria: mean coverage of the corresponding
nominal 95% intervals2, mean absolute percent bias, and mean interval width.
Our study can be compactly summarized in the form of a pseudo-algorithm, dis-
played below:
2To be clear, Bayesian posterior predictive intervals for MI and confidence intervals for NSMIT,
HGSMIT, LR and PR.
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Algorithm 1: Overview of simulation study
for each of the 64 simulation conditions do
(a) generate 100 complete population cohort datasets;
(b) generate 100 realized sample cohort datasets;
repeat steps (a) & (b) if perfect separation occurs;
for each realized sample cohort dataset do
apply PrepDA as outlined in Section 2.2.3;
run logistic and probit regressions as outlined in Section 2.2.3;
evaluate frequentist properties of each method by computing:
mean coverage
mean absolute percent bias
mean interval length
2.2.5 Results and discussion
Table 2.5 below provides a summary of generated population cohort data.
Table 2.5: Summary of generated population cohort data, across the 64⇥100 generated
datasets.
Min 1st quartile Median 3rd quartile Max
1
N
P
Yi(0) < 0.001 0.030 0.056 0.103 0.206
1
N
P
Yi(1) < 0.001 0.030 0.056 0.104 0.198
⌧FP -0.149 -0.030 0.000 0.030 0.143
!FP 0.000 0.4829 1.000 2.031 107.300
The number of units in our generated sample cohort datasets ranged from 80 to
282, with a median of 158.
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Population cohort risk di↵erence ⌧FP
Mean coverage of nominal 95% intervals (See Table 2.6). MI has ap-
proximately 92-94% coverage in all conditions except when B = 1 and the probit
link is used. In that case, it under-covers the true risk di↵erence. Nominal 95%
intervals generated by NSMIT have approximately 97%-98% coverage when data is
generated using the logistic link. Otherwise, coverage varies both by levels of B and
treatment e↵ect. When B = 0, NSMIT yields approximately nominal coverage. The
method under-covers when B = 1, with under-coverage being more significant in the
presence of a treatment e↵ect. We speculate this to be in part due to departures
from the large-sample Normality assumptions that are required for the construction
of Neymanian confidence intervals. In fact, under several simulation conditions, gen-
erated sample cohort datasets had as little as 100 units, 5 of which are cases. After
subclassification, this entailed even smaller sample sizes. Also note that, under our
simulation conditions, parameters ✓ are not sampled from posited generative prior
distributions. For this reason, small departures from nominal coverage are expected.
Finally, note that for both methods, coverage is in general higher when the logistic
link is used to generate data. This is as expected, given the slightly wider tails of the
logistic data generative model.
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Table 2.6: Mean coverage of nominal 95% interval for ⌧ .
⇤No treatment e↵ect is defined in terms of super-population parameters  . That is,
 (0)0 =  
(1)
0 and  
(0)
X =  
(1)
X .
No treatment e↵ect⇤ Treatment e↵ect
Method B \ DGP link Probit Logit Probit Logit
MI
0 .93 .94 .93 .92
1 .83 .94 .84 .92
NSMIT
0 .96 .98 .94 .97
1 .83 .98 .66 .97
Mean absolute percent bias (See Table 2.7). Under correct model speci-
fication, MI produces more bias when B = 1 than when B = 0. In all simulation
settings, NSMIT produces less biased estimates than MI, as expected. In particular,
under correct model specification and when B = 1, the di↵erence between mean ab-
solute percent bias produced by MI and NSMIT is most significant. Namely, there
exists a 2.5 to 4-fold decrease in mean absolute percent bias when NSMIT is applied
in lieu of MI. This demonstrates NSMIT’s e↵ectiveness in reducing pretreatment bias
in the estimation of the risk di↵erence estimand.
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Table 2.7: Mean absolute percent bias (⌧ estimand).
⇤No treatment e↵ect is defined in terms of super-population parameters  . That is,
 (0)0 =  
(1)
0 and  
(0)
X =  
(1)
X .
No treatment e↵ect⇤ Treatment e↵ect
Method B \ DGP link Probit Logit Probit Logit
MI
0 4.39 4.41 0.46 0.54
1 12.17 4.41 2.15 0.54
NSMIT
0 3.96 4.37 0.42 0.53
1 2.94 4.37 0.86 0.53
Mean nominal 95% interval width (See Table 2.8). Nominal 95% intervals
are narrow, which is expected given the rarity of outcome. As expected, MI produces
wider intervals when B = 1 than when B = 0: precision decreases when covariate
distributions di↵er between the two treatment groups.
Table 2.8: Mean width of nominal 95% interval for ⌧ .
⇤No treatment e↵ect is defined in terms of super-population parameters  . That is,
 (0)0 =  
(1)
0 and  
(0)
X =  
(1)
X .
No treatment e↵ect⇤ Treatment e↵ect
Method B \ DGP link Probit Logit Probit Logit
MI
0 .06 .10 .06 .10
1 .10 .10 .10 .10
NSMIT
0 .00 .00 .00 .00
1 .00 .00 .00 .00
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Population cohort odds ratio !FP
Mean coverage of nominal 95% intervals (See Table 2.9). 95% intervals
generated by MI cover the odds ratio with approximately the same rate as for the
risk di↵erence estimand. 95% intervals generated by HGSMIT have approximately
98%-99% coverage under no treatment e↵ect, approximately nominal coverage when
the logistic link is used to generate data and a treatment e↵ect exists, and coverage
levels lower than 82% when the probit link is used to generate data and a treatment
e↵ect exists. LR produces approximately nominal coverage when the logistic link is
used to generate data and a treatment e↵ect exists. It slightly under-covers when
the probit link is used and a treatment exists. Otherwise, under the null hypothesis
of no treatment e↵ect, LR typically over-covers the odds ratio. Not surprisingly, PR
yields coverage of approximately 65% when a treatment e↵ect exists (the method is
not intended for odds ratio estimation), and 97% under the null hypothesis of no
treatment e↵ect. As is the case for the risk di↵erence estimand, under logistic link
data generation all methods generate intervals with coverage approximately equal to
or greater than under probit link data generation. Also, coverage rates are generally
higher under the null hypothesis of no treatment e↵ect.
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Table 2.9: Mean coverage of nominal 95% interval for !.
⇤No treatment e↵ect is defined in terms of super-population parameters  . That is,
 (0)0 =  
(1)
0 and  
(0)
X =  
(1)
X .
No treatment e↵ect⇤ Treatment e↵ect
Method B \ DGP link Probit Logit Probit Logit
MI
0 .93 .93 .92 .92
1 .83 .93 .85 .92
HGSMIT
0 .99 .98 .82 .95
1 .98 .98 .70 .95
LR
0 .98 .98 .94 .95
1 .98 .98 .92 .95
PR
0 .98 .97 .66 .68
1 .97 .97 .63 .68
Mean absolute percent bias (See Table 2.10). Similarly to the pattern
observed for NSMIT in the estimation of risk di↵erence, HGSMIT is most e↵ective
in reducing bias under correct model specification and when B = 1. In this setting,
the estimates it generates are less biased than those generated by LR and PR. Under
logistic link data generation, the HGSMIT estimator has slightly larger mean absolute
percent bias than that of LR. This di↵erence is negligible under the null hypothesis
of no treatment e↵ect (2% di↵erence), and somewhat more prominent under non-
null treatment e↵ect (9% di↵erence). We note that LR is more sensitive to model
misspecification, in that HGSMIT’s advantage over LR is greater under probit link
data generation (with as much as a 6-fold reduction in bias) than is LR’s advantage
over HGSMIT under logistic data generation (with at most a 1.2-fold reduction in
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bias). Also, under correct link function specification, HGSMIT outperforms MI in all
but the setting of a non-null treatment e↵ect and when B = 0. While this exception
requires further theoretical investigation, the former observation is expected, and
is due to trimming and subclass-specific estimation of odds ratios in HGSMIT. In
contrast, HGSMIT adds bias in the overall estimation of the odds ratio when the
logistic link is used to generate data; that is, in situations in which MI seems to
already be accurately estimating !FP . This was anticipated in Section 2.1.2. Lastly,
note that while B significantly influences mean absolute percent bias under probit
link data generation, it has no e↵ect whatsoever when the logistic link is used.
Table 2.10: Mean absolute percent bias (! estimand).
⇤No treatment e↵ect is defined in terms of super-population parameters  . That is,
 (0)0 =  
(1)
0 and  
(0)
X =  
(1)
X .
No treatment e↵ect⇤ Treatment e↵ect
Method B \ DGP link Probit Logit Probit Logit
MI
0 0.72 0.23 0.67 0.25
1 2.72 0.23 3.41 0.25
HGSMIT
0 0.30 0.25 1.11 0.34
1 0.39 0.25 1.45 0.34
LR
0 0.59 0.23   100 0.29
1 2.67 0.23 2.61 0.29
PR
0 0.31 0.14 0.86 0.32
1 0.66 0.14 1.96 0.32
Mean nominal 95% interval width (See Table 2.11). When a probit link
is used to generate data, both LR and PR yield notably wide confidence intervals.
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This merits further theoretical investigation. With non-overlap between covariate
distributions in the two treatment groups, HGSMIT produces narrower intervals than
MI under correct model specification (i.e., probit link) and wider intervals otherwise.
When data is generated via the logistic link, LR produces wider intervals than MI,
but slightly narrower intervals than HGSMIT. The substantive e↵ect of B on mean
interval width is the same as it is on mean absolute percent bias. All four methods
produce narrower intervals when the null hypothesis of no treatment e↵ect holds.
Table 2.11: Mean width of nominal 95% interval for !.
⇤No treatment e↵ect is defined in terms of super-population parameters  . That is,
 (0)0 =  
(1)
0 and  
(0)
X =  
(1)
X .
No treatment e↵ect⇤ Treatment e↵ect
Method B \ DGP link Probit Logit Probit Logit
MI
0 3.73 1.15 7.95 1.52
1 11.96 1.15 13.95 1.52
HGSMIT
0 3.76 1.72 5.92 2.36
1 3.51 1.72 4.04 2.36
LR
0 13.91 1.48 72.86 2.08
1   100 1.48   100 2.08
PR
0   100 0.82   100 0.93
1   100 0.82   100 0.93
Summary
Our simulations show that NSMIT and HGSMIT generally yield reasonable cov-
erage rates for nominal 95% intervals for ⌧ and !, although there are also indications
of the methods’ failure to perform satisfactory in more challenging situations (e.g.,
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in the presence of covariate imbalance). Said methods’ mean percent bias reduction
properties are as expected: when there exists non-overlap in covariate distributions
between the two treatment groups, NSMIT and HGSMIT are both e↵ective in re-
ducing bias, except when MI, in the preceding step 1 of PrepDA, produces accurate
estimates of the risk di↵erence and odds ratio, respectively. In these settings, NSMIT
and HGSMIT are prone to introducing minor noise in the overall estimation of causal
e↵ects. Moreover, HGSMIT generally yields similar results to LR in our controlled
simulation settings with the presence of one covariate only. HGSMIT (and MI), how-
ever, appears to be less sensitive to link function misspecification than LR and PR
with regards to its bias reduction and mean interval width properties.
We expect PrepDA’s analytical advantage over regression adjustment to better
materialize in practical settings. For one, dangers of linear extrapolation can be
significant with the latter method, especially in high dimensional observational stud-
ies. Step 2 of PrepDA should attenuate this problem. Second, regression-based data
snooping — which PrepDA disallows — can substantially impact analysis results, as
will be shown in Chapter 3.
Of note, Appendix A.2 outlines a Bayesian method for inferring causal e↵ects from
case-noncase data under the setup of framework 1.2, but with covariates suppressed.
Our simulations show that this method has properties similar to those of Woolf’s
(1955) well-accpeted procedure for the estimation of !SP . In addition, our method
produces credible intervals that achieve nominal 95% coverage.
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On the application of PrepDA in practice
Because of the goal of our simulation study (to assess frequentist properties of
PrepDA), its setting (presence of one covariate only), and the automated nature of
the procedure, we did not in our algorithm check for overlap in covariate distributions
between the two treatment groups. We advise that analysts perform this crucial step
when implementing PrepDA in practice. Also note that the population to which
causal findings apply can change if data trimming occurrs. This should also be taken
into consideration in practical settings.
2.2.6 Extension to multivariate normal model
The model from 2.2.1 for population cohort data readily extends to multivariate
normal X, as follows. Let p 2 (0, 1). Marginally, the assignment of each unit i is
modeled independently with a Bernoulli(p) distribution:
Wi|p ⇠ Bern(p). (2.22)
Let µ0 := (1, µ
(0)
1 , · · · , µ(0)k )T , µ1 := (1, µ(1)1 , · · · , µ(1)k )T 2 Rk, ⌃0,⌃1 2 Sk++3 and
p 2 (0, 1). Then, for all i, independently and conditionally on treatment received Wi,
we let the 1⇥k vector of covariates xi := (Xi1, · · · , Xik) follow a multivariate Normal
distribution with mean µWi and variance ⌃Wi :
xi|Wi,µWi ,⌃Wi ⇠MVN (µWi ,⌃Wi) (2.23)
3Sn++ = {A 2 Rn⇥n : A = At and xTAx > 0 for all x 2 Rn such that x 6= 0}
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Specifications 2.22 and 2.23 induce the following assignment mechanism:
Pr(Wi = w|xi,µ0,µ1,⌃0,⌃1, p) =
pw(1  p)(1 w) ·  k(xi;µw,⌃w)
(1  p) ·  k(xi;µ0,⌃0) + p ·  k(xi;µ1,⌃)
,
(2.24)
for w 2 {0, 1}. Next, let  (j) = ( (j)0 , · · · ,  (j)k )T 2 Rk+1 for j 2 {0, 1}, and exi :=
(1, Xi1, · · · , Xik) 2 R1⇥(k+1). For all i, and given the vector of covariates xi, potential
outcomes Yi(0) and Yi(1) are modeled independently according to the following two
probit models:
Pr(Yi(0) = 1|xi, (0)) =  (exi ·  (0)) (2.25)
Pr(Yi(1) = 1|xi, (1)) =  (exi ·  (1)) (2.26)
Finally, let the sampling mechanism as in equation (2.8).
Let the set of parameters from the above model be represented by ✓, where
✓ = (p,µ0,⌃0,µ1,⌃1, 
(0), (1)). (2.27)
In addition, let eµj := (1, µ(j)1 , · · · , µ(j)k )T 2 Rk+1 for j 2 {0, 1} and
e⌃W :=
               
0 0 · · · 0
0
...
0
⌃W
               
.
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The observed log-likelihood is thus:
`(✓|Y˜ obs) =
X
i:Sr, ·i =1
(
W ·, inci Y
r, inc
i log[ (ex·, inci  (1))]
+W ·, inci (1  Y r, inci )log[1   (ex·, inci  (1))]
+ (1 W ·, inci )Y r, inci log[ (ex·, inci  (0))]
+ (1 W ·, inci )(1  Y r, inci )log[1   (ex·, inci  (0))]
+ (1 W ·, inci )log[ k(x·, inci ;µ0,⌃0)]
+W ·, inci log[ k(x
·, inc
i ;µ1,⌃1)]
+W ·, inci log[p] + (1 W ·, inci )log[1  p]
)
+ (N   ninc)
⇥ log
"
1  (1  p) ·  
( eµT0  (0)q
1 +  (0)
T e⌃0 (0)
)
  p ·  
( eµT1  (1)q
1 +  (1)
T e⌃1 (1)
)#
(2.28)
where ninc :=
P
i S
r, ·
i , ✓ as in (2.27) and Y˜
obs
= (Sr, ·,Y r, inc,W ·, inc,X ·, inc).
A strategy, analogous to that presented in Section 2.2.3, for statistical inference
under the above model, is given in Appendix A.3.
67
Chapter 3
PrepDA and logistic regression,
contrasted: a reanalysis of data
from Karkouti et al. (2006)
3.1 Objectives, background, and analysis outline
3.1.1 Objectives of this chapter
In a study analogous to LaLonde (1986) and Dehejia and Wahba (2002), we inves-
tigate whether PrepDA and logistic regression, when applied to case-noncase data,
can generate estimates that are concordant with those from the causal analysis of
population cohort data. The purpose of our work is to (a) illustrate the application
of PrepDA in the context of a real-life example, (b) investigate consistency, or lack
thereof, between results obtained via the application of PrepDA and logistic regres-
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sion to sample cohort data, and those derived from the causal analysis of population
cohort data, (c) introduce tools for covariate balance assessment across multiple im-
puted datasets, and (d) explore the potential for analyst bias with logistic regression,
when said method is used to analyze case-noncase data. To this end, we focus on the
re-analysis of a subset of data from a published article, Karkouti et al. (2006), which
we detail below.
3.1.2 Example dataset: Karkouti et al. (2006)
Karkouti et al. (2006) concerns a prospective nonrandomized study of two drugs,
aprotinin1 and tranexamic acid2, in patients who underwent cardiac surgery at the
Toronto General Hospital from 1999 to 2004. Aprotinin and tranexamic acid are both
used to prevent or treat excessive blood loss during complex surgery, such as cardiac
surgery. Until 2006, aprotinin was generally considered to be superior to trenexamic
acid, despite a lack of supporting clinical evidence (Linden, 2003; Karkouti et al.,
2006). Karkouti et al. (2006) investigates the drugs’ relative clinical utility and safety
on a variety of outcomes, such as postoperative risk of blood product transfusion,
stroke, infection, and mortality.
3.1.3 Construction of realized population cohort dataset
From data used in Karkouti et al. (2006), we construct a sub-dataset for pur-
poses of our analysis. We select eight key covariates, and construct another four
1Trasylol, produced by Bayer AG, Toronto, Ontario, Canada.
2Cyclokapron, produced by Pharmacia & UpJohn Inc., Mississauga, Ontario, Canada.
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by summing indicator variables related to the following clinical attributes: heart
surgery history, clinical presentation, coronary artery disease risk, and coronary artery
disease-associated illness. Table 3.1 details our resulting set of covariates. We con-
sider as primary outcome postoperative renal failure, defined as new requirement for
dialysis support3, and selected for its rarity (approximate rate of 1.90%). Of note,
we disregard patients with missing covariate or outcome data. The ensuing realized
population cohort dataset comprises Npop = 7, 416 patients, of whom 407, or 5.49%,
received aprotinin, and of whom nc = 141 are cases (i.e., patients with postoperative
renal failure).
3Dialysis is a process for removing waste and excess water from the blood, and is used primarily
as an artificial replacement for lost kidney function in people with renal failure (Medicine Net Sta↵,
2014).
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Table 3.1: Description of covariates in constructed dataset.
The first six covariates appear in the original dataset; that last four were constructed.
⇤Endocarditis is an infection of the inner lining of the heart (Mayo Clinic Sta↵, 2014a).
†An elective admission is a surgery that is scheduled in advance, because it does not
involve a medical emergency (Mosby, 2009).
‡Platelets, or thrombocytes, are colorless blood cells that play an important role in
blood clotting. Platelets stop blood loss by clumping and forming plugs in blood
vessel holes (Mayo Clinic Sta↵, 2014b).
Name Description
Levels (if applicable)
or example
type.surg type of surgical procedure isolated bypass, valve, other
act.endoc indicator for active endocarditis⇤ none, remote, active, active abscess
pre.HB
preoperative hemoglobin (HB)
concentration in dag/dL
elective.surg indicator for non-elective† admission elective, admission
age patient age
sex patient sex female, male
area patient body surface in m2
plt.count platelet‡ count in 106/L
prev.surg
sum of indicators for
previous heart surgeries
e.g., aortic valve surgery
clinical
sum of indicators for
clinical presentation variables
e.g., most recent
myocardial infarction
cad.risk
sum of indicators for
coronary artery disease (CAD) risks
e.g., diabetes
asst.dis
sum of indicators for
diseases associated with CAD
e.g., previous stroke
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3.1.4 Generation of realized sample cohort dataset
From the aforementioned constructed dataset, we generate a synthetic case-noncase
sample. Following the case-cohort study design, we sample all cases, and take a simple
random sample of 10% of the noncases. The resulting realized sample cohort dataset
consists of Nsample = 868 patients, of whom 76, or 8.76%, received aprotinin.
3.1.5 Outline of analysis strategy
Our strategy for data analysis is as follows. In Section 3.2, we perform the —
benchmark — causal analysis of population cohort data. In Sections 3.3 and 3.4,
we analyze sample cohort data using PrepDA and logistic regression, respectively.
Estimands of interest are the super-population risk di↵erence,
⌧SP = Pr(Y (1) = 1)  Pr(Y (0) = 1), (3.1)
and the super-population causal odds ratio,
!SP =
Pr(Y (1) = 1)
Pr(Y (1) = 0)
,
Pr(Y (0) = 1)
Pr(Y (0) = 0)
, (3.2)
in Sections 3.2 and 3.3, and the super-population conditional associative odds ratio,
!SP |W,x =
Pr(Y (W ) = 1|W = 1,x)
Pr(Y (W ) = 0|W = 1,x)
,
Pr(Y (W ) = 1|W = 0,x)
Pr(Y (W ) = 0|W = 0,x) , (3.3)
in Section 3.4.
Henceforth, we define “receipt of aprotinin” as active treatment, and “receipt of
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tranexamic acid” as control treatment. Considering the context of our study, SUTVA
holds. In addition, we assume unconfoundedness of the assignment mechanism, de-
spite having chosen for analysis only a subset of pretreatment variables considered by
Karkouti et al.
3.2 Causal analysis of realized population cohort
dataset
In this section, we estimate the causal e↵ect of aprotinin versus tranexamic acid
on postoperative renal failure, using the realized population cohort dataset. In doing
so, we follow Rubin’s guidelines for the design and analysis of observational studies
(Rubin, 2007).
3.2.1 Design of observational data
Via logistic regression, we estimate propensity scores using all twelve covariates
available in the dataset. We run a 1:1 greedy nearest neighbor matching algorithm
(Rubin, 1973a) to select, out of a pool of 7009 control patients, 407 matches for
treated patients, based on their proximity on propensity score distance. Figures 3.1-
3.3 and Table 3.2 summarize the result of our algorithm. That is, matching yields an
overall satisfactory balance in covariate distributions between active treatment and
control treatment units. In particular, Figures 3.2 and 3.3 demonstrate an overlap
in estimated propensity scores between the control and treated subpopulations, after
matching. Table 3.2 and Figure 3.1 show a notable improvement in balance of covari-
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ate means for all 12 covariates, also after matching. In addition, t-tests (Table B.1,
Appendix B.1) suggest non-significant di↵erences in covariate means, post-matching,
between the two treatment groups, at the 0.05 significance level for all covariates but
prev.surg.
E↵orts were not undertaken to prioritize a subset of covariates for matching, given
the illustrative, as opposed to scientifically investigative, nature of our analysis.
Table 3.2: Mean within each treatment group for each covariate, before and after
matching.
Note: TA stands for tranexamic acid.
Initial After matching
X¯aprtotinin X¯TA X¯aprotinin X¯TA
type.surg 2.56 1.47 2.56 2.61
act.endoc 0.10 0.01 0.10 0.08
pre.HB 126.66 133.98 126.66 128.99
elective.surg 0.44 0.42 0.44 0.42
age 55.37 62.86 55.37 55.64
sex 1.37 1.26 1.37 1.38
area 0.19 0.03 0.19 0.19
plt.count 8.94 1.93 8.94 8.20
prev.surg 1.08 0.09 1.08 0.84
clinical 5.57 6.55 5.57 5.43
cad.risk 1.83 3.12 1.83 1.78
asst.dis 0.72 0.44 0.72 0.71
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Figure 3.1: Standardized di↵erence in means, initial and after matching, for covari-
ates.
Note: to ensure fair before and after comparison, post-matching di↵erences in means
were standardized using the estimate of the variance of di↵erences in means before
matching. Displayed post-matching statistics are thus not t-statistics in the conven-
tional sense.
Vertical lines appear at standardized di↵erences in means of -2, 0 and 2, respectively.
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Figure 3.2: Histograms of estimated
propensity scores, by treatment, before
matching.
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Figure 3.3: Histograms of estimated
propensity scores, by treatment, after
matching.
3.2.2 Analysis outline and results
We apply Neyman’s method and simple linear regression on matched data to
estimate ⌧SP . We use Woolf’s method4 and logistic regression, also on matched data,
to estimate !SP . In both regression models, postoperative renal failure is regressed
on the indicator for receipt of aprotinin, and all twelve covariates. Regression is
used to adjust for any residual imbalance in covariate distributions (e.g., on variable
prev.surg) between the active treatment and control treatment subgroups (Rubin and
Stuart, 2007). Rubin (1973b, 1979); Robins and Rotnitzky (1995); Heckman et al.
(1997); Rubin and Thomas (2000) discuss the benefits of combining regression with
matching. Our results are displayed in Table 3.3 below. Results from the application
of the above methods on unmatched data are also included, for reference.
4Woolf’s estimator and Haldane’s (1955) approximately unbiased estimator produced approxi-
mately identical estimates of the odds ratio.
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Table 3.3: Causal analysis of realized population cohort dataset: results.
Unmatched group Matched group
estimand method point estimate 95% CI point estimate 95% CI
risk di↵erence
Neyman 0.071 (0.043, 0.098) 0.012 (-0.025, 0.050)
Regression 0.017 (0.001, 0.032) 0.004 (-0.031, 0.038)
odds ratio
Woolf 6.13 (4.12, 9.10) 1.18 (0.71, 1.97)
Regression 1.66 (0.95, 2.91) 1.34 (0.74, 2.44)
Our analysis concludes a non-significant causal e↵ect of aprotinin versus tranex-
amic acid on postoperative renal failure at the 0.05 significance level, for both the risk
di↵erence and odds ratio estimands. Neyman and linear regression yield estimates of
1.2% and 0.4%, respectively, for the risk di↵erence. Woolf and logistic regression es-
timate the odds ratio at 1.18 and 1.34, respectively. Given our use of well-established
causal inference methods in the above analysis, we regard these findings as bench-
marks.
3.3 Causal analysis of realized sample cohort dataset
via PrepDA
In this section we estimate the causal e↵ect of aprotinin versus tranexamic acid
on postoperative renal failure, this time using realized sample cohort data. We im-
plement the three steps of PrepDA (Section 2.1.1), barring the presence of two inde-
pendent parties, to estimate ⌧SP and !SP , as follows.
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3.3.1 Step 1: preprocessing
Exploiting the fact that, within the confines of our study, population cohort data
is known, we impute missing realized population cohort data,
Y˜
mis
= (Y r, exc,W ·, exc,X ·, exc),
by drawing from the empirical approximation of the true conditional distribution of
missing data given the observed data, Pr(Y˜
mis|Y˜ obs), where Y˜ obs is defined as in
(1.20). We refer the reader to Appendix B.4 for further details. We thus generate a
total of M = 20 imputed population cohort datasets5.
This imputation strategy, although generally impracticable, ensures the imple-
mentation of PrepDA under correct imputation model specification. Furthermore,
it circumvents the current limitations of our methodology; that is, to normally dis-
tributed covariates and probit link function specification. Also note that the method
here circumvents the imputation of missing potential outcome data. In practice,
we recommend that analysts posit an imputation model on the complete population
cohort data matrix so as to adequately model all relevant data.
Figure 3.4 summarizes the result of our imputation procedure for covariate pre.HB.
It depicts, for active treatment units, histograms of said covariate, in both the pop-
ulation cohort and sample cohort. It also depicts superimposed densities from all 20
imputed population cohort datasets. As expected, distributions of pre.HB di↵er in
the population and sample cohort. This distortion is due to the confounded nature
5Our results were insensitive to additional imputations.
78
Chapter 3: PrepDA and logistic regression, contrasted: a reanalysis of data from
Karkouti et al. (2006)
of the realized sampling mechanism. (See Figures B.1 and B.2 in Appendix B.2 for
additional histograms.) What’s more, we observe that the imputed pre.HB data is in
agreement with “true”, population cohort, pre.HB data. That is, our imputation pro-
cedure successfully re-creates a stochastic version of the realized population cohort,
shown here for covariate pre.HB.
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Figure 3.4: Histogram/density of pre.HB variable in realized population cohort, real-
ized sample cohort, and imputed realized population cohort.
3.3.2 Design
We apply the matching algorithm from Section 3.2.1 to each imputed dataset. We
then assess overall covariate balance. To this end, we construct two types of plots
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which, in our opinion, together e↵ectively summarize balance of covariate means
across imputed datasets. The first plot, pictured in Figure 3.5, is an extension of Fig-
ure 3.1. It displays standardized di↵erences in means for all covariates in all imputed
datasets, before and after matching. In our example, we note an improvement in
average balance of covariate means, after matching, for all covariates. Further, with
the exception of prev.surg, di↵erences in standardized means are desirably concen-
trated around the null value. The second type of plot, in Figures 3.6 and 3.7, depicts
(relative) changes in standardized di↵erences in means, pre to post-matching, in all
imputed datasets, for a given covariate. This plot conveys the share of datasets within
which matching improved, or worsened, balance. In our example, balance improved
significantly across all datasets for covariate type.surg in uniform fashion. Such is,
however, the case in only 11 out of the 20 datasets for elective.surg. Nonetheless,
type.surg is well-balanced post-matching.
Note that the two preceding plots can be amended to display alternative met-
rics, such as di↵erences in covariate quantiles between the two treatment subgroups.
Examples of additional balance metrics and visual balance diagnostics are:
• Metrics for assessment of overall balance:
– Average, taken over M imputed datasets, mean Mahalanobis distance be-
tween covariate values of units in the active treatment and control treat-
ment subgroups.
– Proportion of covariates whose average balance improved upon matching.
• Metrics for assessment of balance for a given covariate:
80
Chapter 3: PrepDA and logistic regression, contrasted: a reanalysis of data from
Karkouti et al. (2006)
– Median di↵erence, across imputed datasets, in covariate ranges between
active treatment and control treatment units.
– Proportion, out of those imputed datasets for which initial balance was
unsatisfactory, of datasets with satisfactory balance after matching.
• Visual diagnostics:
– Plot of superimposed densities, as in Figure 3.4, of estimated propensity
scores under active treatment and control treatment regimes.
– Plot of superimposed densities of key covariates under active treatment
and control treatment regimes.
Weighting the above metrics according to importance of covariates provides yet
anther extension.
Further inspection of histograms and estimated propensity scores from each of our
imputed datasets (omitted here) confirmed satisfactory covariate balance.
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Figure 3.5: Standardized di↵erence in means, initial and after matching, for covari-
ates, for 20 imputed datasets.
Note: to ensure fair before and after comparison, post-matching di↵erences in means
were standardized using the estimate of the variance of di↵erences in means before
matching. Displayed post-matching statistics are thus not t-statistics in the conven-
tional sense.
Vertical lines appear at standardized di↵erences in means of -2, 0 and 2, respectively.
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Figure 3.6: Standardized di↵erences in
means for variable type.surg, for 20 im-
puted datasets.
Reduced absolute di↵erence in means af-
ter matching are represented in blue.
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Figure 3.7: Standardized di↵erences in
means for variable elective.surg, for 20
imputed datasets.
Reduced absolute di↵erence in means af-
ter matching are represented in blue. In-
creased, in red.
3.3.3 Analysis outline and results
We obtain point estimates and 95% confidence intervals for ⌧SP and !SP (see
Table 3.4) by applying methods from Section 3.2.2 to each imputed realized popula-
tion cohort dataset, and combining ensuing results using Rubin’s rules for multiple
imputation (Rubin, 1987).
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Table 3.4: Causal analysis of realized sample cohort dataset via PrepDA: results.
estimand method point estimate 95% CI
risk di↵erence
Neyman 0.013 (-0.025, 0.052)
Regression 0.005 (-0.033, 0.043)
odds ratio
Woolf 1.20 (0.71, 2.05)
Regression 1.34 (0.69, 2.62)
Table 3.4 above indicates that all methods yield point estimates and confidence
intervals that are in close agreement with population cohort analysis benchmarks
(Table 3.3).
3.4 Associative analysis of realized sample cohort
dataset via logistic regression
In this section, we use logistic regression to analyze, once again, the realized
sample cohort dataset. In addition, we explore the potential for analyst bias with
logistic regression methods.
3.4.1 Analysis outline and results
We analyze data according to the following pre-specified protocol. We regress post-
operative renal falure on the indicator for aprotinin receipt and all twelve covariates.
We also fit a model with all main e↵ects and 2-way interactions between covariates.
Then, starting with the aforementioned models, we run forward and backward step-
wise model selection (Hocking, 1976), using both the AIC (Akaike, 1973) and BIC
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(Gideon, 1978) information criteria. Point estimates and 95% confidence intervals for
the associative odds ratio, !SP |W,x, are reported in Table 3.5 below.
Table 3.5: Associative analysis of realized sample cohort dataset via logistic regression:
results.
baseline model model selection method point estimate 95% CI
main e↵ects
none 2.62 (1.21, 5.69)
forward model selection (AIC) 2.62 (1.21, 5.69)
backward model selection (AIC) 2.33 (1.16, 4.71)
forward model selection (BIC) 2.62 (1.21, 5.69)
backward model selection (BIC) 2.01 (1.01, 3.99)
main e↵ects and
2-way interactions
none 2.96 (1.06, 8.27)
forward model selection (AIC) 2.96 (1.06, 8.27)
backward model selection (AIC) 3.10 (1.16, 8.29)
forward model selection (BIC) 2.96 (1.06, 8.27)
backward model selection (BIC)† 2.21 (0.96, 5.08)
As can be seen, results generated by the above regression models stand in contrast
to population cohort analysis benchmarks (Table 3.3). In particular, none of the
estimates are contained within the 95% confidence intervals produced by Woolf’s
method, and only 3 out of the 10 estimates fall within the regression-generated interval
from Section 3.2. What’s more, 9 out of 10 outputs suggest a statistically significant
relationship between aprotinin intake and postoperative renal failure, which stands
in disagreement with benchmark results (as well as with model †, Table 3.5, results).
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3.4.2 The perils of logistic regression
Table 3.5 shows that standard model selection procedures alone can produce two
sets of results that imply substantively di↵ering study conclusions. So as to further
explore the potential for analyst bias, we distort, to the extent possible, regression
results by means of deliberate model selection. The outcome of this exercise — i.e.,
the resulting two models with most contrast results — is presented in Table 3.6.
Model details are provided in Appendix B.5.
Table 3.6: Associative analysis of realized sample cohort dataset via logistic regression,
with analyst bias: results.
model point estimate CI Hosmer-Lemeshow test p-value
1 2.11 (0.89, 4.99) 0.79
2 3.78 (1.36, 10.54) 0.11
The first model indicates a non-significant association between intake of aprotinin
versus tranexamic acid, and postoperative renal failure. The second suggests oth-
erwise, and yields an estimate of the odds ratio that is approximately 1.8-fold that
generated by model 1. Both models fit the data well per the Hosmer-Lemoshow test,
and are arguably reasonable in that they were obtained by simply adding quadratic
terms to models from Section 3.4.1 analysis.
The above exercise shows that regression, applied to case-noncase data, provides
analysts with ample opportunity to fish for sought-after results.
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3.5 Conclusion
We showed that, when applied to sample cohort data, and under the assumption
of correct imputation model, our technology can produce estimates for the super-
population risk di↵erence and odds ratio that are in agreement with those obtained
via application of standard causal inference methods to population cohort data. These
findings demonstrate — if only conceptually, in the artificial setting of known imputa-
tion model — the potential of PrepDA for the analysis of real-life case-noncase study
data.
In contrast, disparities between estimates of the associative odds ratio generated
by logistic regression on case-noncase data, and estimates of the causal odds ratio
produced by a prospective causal analysis, suggest that regression methods may be
inappropriate for purposes of causal inference with case-noncase data. This fact was
previously established for prospective designs (see, e.g., Cochran, 1957; Cochran and
Rubin, 1973; Rubin, 1973b, 2001).
Last but not least, our study demonstrates the perils of logistic regression with
regards to objectivity of (causal) analysis. Our empirical example shows that regres-
sion adjustment can be misused, via intentional model construction and selection, on
case-noncase data, to produce biased results. PrepDA guards against such practice.
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Discussion and future work
The causal inference framework introduced in Chapter 1 extends the many ben-
efits of the Rubin Causal Model to retrospective studies. Through formulation of
the case-noncase study as a cohort study with missing data, our approach fills a
conceptual gap between (observational) prospective cohort studies and retrospective
studies. Conceptual coherence ensues: a case-noncase study is a partially observed
cohort study, which itself is a broken stratified randomized experiment. The problem
of causal inference for retrospective studies is therefore conceptually identical to that
for cohort studies: the challenge is to reconstruct, to the extent possible, the broken
randomized experiment.
Much like the RCM, our approach focuses on first principles: problem definition,
framework setup, missing data theory, and Bayesian multiple imputation. This, in
turn, allows for clear formulation of assumptions (e.g., unconfoundedness) made in
reaching causal conclusions. It also discourages the careless application of standard
statistical techniques, such as regression adjustment, for purposes of causal analysis
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— the inclusion of outcome variables as predictors in a regression model comes to
mind. Last but not least, our approach provides a deeper understanding of the
causal inference problem for case-noncase studies than traditional methodologies. For
instance, as shown in Section 1.2.9, the potential outcomes perspective sheds new
light on the age-old controversy over the use of retrospective matching. The benefits
of potential outcomes-based causal inference, and of the missing data perspective in
applied and theoretical statistical problems, are further discussed in Rubin (2005a,b).
Our recommendation is that analysts ask a series of key questions when tackling
any given causal inference problem with case-noncase data. These include, but are
not limited to, “What estimand is of practical relevance?”, “How and why is the
case-noncase study better suited to addressing the problem?”, “Is the assignment
mechanism unconfounded?”, “Is the population cohort well-defined?”, “What scien-
tific knowledge can be incorporated into the study?”, and “How should potential
outcomes be modeled?”.
A fundamental di↵erence between our approach and the framework underlying
logistic regression is that the estimand is not forced to be a parameter in some super-
population model. As shown in Chapters 1 and 2, our technology allows for the defini-
tion, and inference, of population cohort (i.e., finite population) causal estimands, and
thereby focuses on quantities that we believe are of greater practical interest. In con-
trast, most epidemiological techniques generally focus on abstract super-population
statistical quantities. What’s more, our estimands are, by definition, causal. This is
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in contrast to the oft-studied “associative” odds ratio
Pr(Y (W ) = 1|W = 1)
Pr(Y (W ) = 0|W = 1)
,
Pr(Y (W ) = 1|W = 0)
Pr(Y (W ) = 0|W = 0) (4.1)
(and other standard measures of association) which, as Holland and Rubin (1988)
demonstrate, has generally no causal relevance. Lastly, the choice of estimand is
flexible under our approach. That is to say, analyses are not restricted to logistic
and other multiplicative intercept models (as argued by Wacholder, 1996), nor to the
associative odds ratio, which is ubiquitous in epidemiological studies, in part because
of its non-sensitivity to choice of sampling design (prospective or retrospective; see,
e.g., Bishop et al., 1975). The NSMIT method, introduced in Section 2.2, for instance,
can estimate the population cohort risk di↵erence.
PrepDA guarantees objectivity, to the extent we believe is possible, in the esti-
mation of causal e↵ects from case-noncase data. In contrast, as shown in Chapter
3, regression adjustment can be misused, via intentional model construction and se-
lection, to produce biased results. Moreover, our findings suggest that regression
methods may be inappropriate for purposes of causal inference with case-noncase
data.
From a methodological perspective, our technology allows for the application of the
widely-accepted matched sampling methods for pretreatment bias reduction (Rubin,
2006; Imbens and Rubin, 2015) to retrospectively collected data, post-data prepro-
cessing. It also enables, and should encourage, investigators to assess the validity of
their causal findings, e.g. by checking for overlap in covariate distributions between
treatment groups, also post-preprocessing. A standard pre-specified analysis (e.g.,
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pre-specified regression analysis) of case-noncase data, though objective, does not.
Also, PrepDA can be extended to accommodate secondary outcome analysis, via
incorporation of secondary outcomes into the model for population cohort potential
outcomes. Future work will explore this topic.
Our simulations show that PrepDA-based methods NSMIT and HGSMIT gen-
erally yield reasonable coverage rates, although they under-cover in the presence of
covariate imbalance. Also, both methods are e↵ective in reducing bias, except when
MI produces accurate estimates of the risk di↵erence and odds ratio. In this type
of setting, NSMIT and HGSMIT are prone to introducing minor noise in the overall
estimation of causal e↵ects. In our view, this disadvantage is trumped by the con-
siderable benefit of analyst objectivity guaranteed by PrepDA. Moreover, HGSMIT
generally yields similar results to LR in our controlled simulation settings. However,
the former (and MI) appears to be less sensitive to link function misspecification
than the latter (and PR) with regards to bias reduction and mean interval width
properties.
A disadvantage of our technology, in its current form, however, is its dependence
on party A’s choice of imputation model. Accordingly, future research will investigate
the use of non-parametric imputation methods in the preprocessing step of PrepDA.
The use of spline regression methods, for instance, has been shown e↵ective for the
analysis of prospective observational study data (Gutmanan and Rubin, 2012). Future
research will also focus on the generalization of NSMIT and HGSMIT to more realistic
settings (e.g., in the presence of a mixture of continuous and categorical covariate
data). Thus far, our e↵orts have indicated this to be a di cult undertaking, for
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both analytical and computational reasons. Lastly, our method is computationally
intensive, whereas traditional methods generally are not.
To conclude, our first exploration into bringing objectivity in causal inference
with case-noncase data suggests a tradeo↵ to be had between (a) objectivity of the
analysis of case-noncase data, and (b) inferential simplicity, computational e ciency,
and— potentially — robustness (i.e., non-reliance on modeling assumptions). Despite
the aforementioned shortcomings of PrepDA, the findings of this thesis nevertheless
demonstrate our methodology’s potential for the objective and causal analysis of
real-life case-noncase data.
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Supplement to Chapter 2
A.1 PrepDA, step 1: prior specification and pos-
terior predictive draws
A.1.1 Prior specification on ✓
p ⇠ Beta(2, 2) (A.1)
µ0 ⇠ N (0, 10) (A.2)
 0 ⇠ Inv-Gamma(1.5, 2.5) (A.3)
µ1 ⇠ N (0, 10) (A.4)
 1 ⇠ Inv-Gamma(1.5, 2.5) (A.5)
 (0)0 ⇠ Cauchy(0, 10) (A.6)
 (0)X ⇠ Cauchy(0, 10) (A.7)
 (1)0 ⇠ Cauchy(0, 10) (A.8)
 (1)X ⇠ Cauchy(0, 10) (A.9)
A.1.2 Imputation of Y˜
mis
: drawing from f(Y˜
mis|Y˜ obs,✓)
• For those units for which Sr, ·i = 1:
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1. If W ·, inci = 0:
Pr(Y mis, inci = 1|Y˜
obs
,✓) = Pr(Y mis, inci = 1|Y r, inci ,W ·, inci = 0, X ·, inci , Sr,·i = 1,✓)
= Pr(Y mis, ·i = 1|Y r, ·i ,Wi = 0, Xi, Sr, ·i = 1,✓)
=  ( (1)0 +  
(1)
X Xi) (A.10)
2. If W ·, inci = 1:
Pr(Y mis, inci = 1|Y˜
obs
,✓) = Pr(Y mis, inci = 1|Y r, inci ,W ·, inci = 0, X ·, inci , Sr,·i = 1,✓)
= Pr(Y mis, ·i = 1|Y r, ·i ,Wi = 0, Xi, Sr, ·i = 1,✓)
=  ( (0)0 +  
(0)
X Xi) (A.11)
• For those units for which Sr, ·i = 0:
Given ✓, independently for each i, draw sequentially from conditional distribu-
tions using the following:
1.
Pr(W ·, exci = 1|Y˜
obs
,✓) = Pr(W ·, exci = 1|Sr,·i = 0,✓) (A.12)
=
p ·
h
1   
n
 
(1)
0 + 
(1)
X µ1q
1+ 21 
(1)
X
2
oi
p ·
h
1   
n
 
(1)
0 + 
(1)
X µ1q
1+ 21 
(1)
X
2
oi
+ (1  p) ·
h
1   
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 
(0)
0 + 
(0)
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1+ 20 
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2.
Pr(X ·, exci |Wi = 0, Y˜
obs
,✓) = Pr(X ·, exci |Wi = 0, Sr,·i = 0,✓)
=
(1   { (0)0 +  (0)X xi}) ·  (xi;µ0, 20)
1   
n
 
(0)
0 + 
(0)
X µ0q
1+ 20 
(0)
X
2
o (A.13)
Pr(X ·, exci |Wi = 1, Y˜
obs
,✓) = Pr(X ·, exci |Wi = 1, Sr,·i = 1,✓)
=
(1   { (1)0 +  (1)X xi}) ·  (xi;µ1, 21)
1   
n
 
(1)
0 + 
(1)
X µ1q
1+ 21 
(1)
X
2
o (A.14)
We sample from the above two distributions via grid sampling.
3 . Let
P (i)(j,k)|w := Pr((Yi(0), Yi(1))
mis, exc = (j, k)|Xi,Wi = w, Y˜ obs,✓)
= Pr((Yi(0), Yi(1))
mis, exc = (j, k)|Xi,Wi = w, Sobsi = 0,✓) (A.15)
Then
P (i)(0,0)|0 = 1   ( (1)0 +  (1)X Xi) (A.16)
P (i)(0,0)|1 = 1   ( (0)0 +  (0)X Xi) (A.17)
P (i)(0,1)|0 =  ( 
(1)
0 +  
(1)
X Xi) (A.18)
P (i)(1,0)|1 =  ( 
(0)
0 +  
(0)
X Xi) (A.19)
P (i)(0,1)|1 = P
(i)
(1,0)|0 = P
(i)
(1,1)|0 = P
(i)
(1,1)|1 = 0 (A.20)
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A.2 A potential outcomes alternative to Woolf’s
method for inferring (causal) e↵ects from case-
noncase data: a simulation study
A.2.1 The model
We assume the setup outlined in Section 1.2, with covariates suppressed. Let
p0, p1, , and ⇡ 2 (0, 1). Independently for each unit i, i = 1, · · · , N , in the popu-
lation cohort, we posit the following models for purposes of population cohort data
generation and Bayesian inference:
• Potential outcomes:
Pr(Yi(0) = yi0, Yi(1) = yi1|p0, p1) = p(Yi(0) = yi0|p0) · p(Yi(1) = yi1|p1)
= pyi00 (1  p0)1 yi0 · pyi11 (1  p1)1 yi1 (A.21)
• Assignment mechanism:
Pr(Wi = w|Yi(0), Yi(1), p0, p1, ) =  w(1   )1 w, (A.22)
for w 2 {0, 1}.
• Sampling mechanism:
We assume sampling of all cases, and simple random sampling with known
probability ⇡ of noncases, which yields the following:
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Pr(Si(0) = si0, Si(1) = si1|Wi, Yi(0), Yi(1), p0, p1, ) = p(Si(0) = si0|Yi(0))
⇥ p(Si(1) = si1|Yi(1))
=
 
⇡si0(1  ⇡)(1 si0) 1[Yi(0)=0]
⇥  ⇡si1(1  ⇡)(1 si1) 1[Yi(1)=0]
(A.23)
A.2.2 Choice of priors
Priors were chosen in accordance with parameter simulation settings. We posit:
  ⇠ Beta(2, 2) (A.24)
p0 ⇠ Beta
⇣1
3
, 5
⌘
(A.25)
p1 ⇠ Beta
⇣1
3
, 5
⌘
(A.26)
A.2.3 Simulation study
The following procedure is implemented:
1. Set parameter values {N, p0, p1, ,⇡}, as specified in Table A.1.
2. Repeat, x 1000:
• Given parameter values, generate population cohort data.
• Obtain sample cohort data from population cohort data.
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• Get posterior draws given observed data, using Bayesian model above and
Gibbs sampling. (Note: starting points are sampled from an over-dispersed
distribution. The Gelman-Rubin (G-R) statistic is computed to verify
convergence.) Obtain super-population point estimates of ⌧ and ! and
the corresponding credible intervals by taking the mean and (0.025, 0.975)
quantiles, respectively, of the parameters’ posterior distributions.
• Multiply impute missing data via draws from the posterior predictive dis-
tribution of missing data given observed data. From imputed datasets,
calculate the risk di↵erences and odds ratios. Obtain finite-population
point estimates of ⌧ and ! and the corresponding intervals by taking the
mean and (0.025, 0.975) quantiles, respectively of the two sets of calculated
estimands.
• Compute odds ratio estimates and 95% confidence intervals using Woolf’s
(1955) method for those datasets for which Woolf’s estimates exists (i.e.,
datasets for which all observed data counts nij are nonzero).
3. Assess frequentist properties of above procedures. Namely, for those datasets
to which Woolf’s method applies, compute, for all methods:
• mean coverage (nominal coverage level used: 95%)
• mean absolute percent bias
• mean interval width
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A.2.4 Simulation results
Table A.1: Sample cohort data sample size n¯, % of datasets invalid for comparison,
and G-R statistic (Gibbs).
1‘draw’ refers to drawing from the prior distribution of the parameters.
Parameter values
N p0 p1 !   ⇡
% of
n datasets invalid G-R statistic
for comparison
10,000 .01 .01 1 .5 .01 198 0 1.01
10,000 .005 .005 1 .5 .01 149 0 1.01
10,000 .01 .005 .50 .5 .01 174 0 1.01
10,000 .01 .005 .50 .3 .01 184 0 1.01
10,000 .001 .0005 .50 .5 .01 107 10 1.01
10,000 .001 .0005 .50 .5 .1 1,004 8 1.00
10,000 .1 .01 .09 .5 .01 644 0 1.01
10,000 .01 .009 .90 .5 .01 194 0 1.01
10,000 .005 .01 2.01 .5 .01 173 0 1.01
10,000 .005 .01 2.01 .3 .01 164 0 1.01
10,000 .0005 .001 2.00 .5 .01 107 9 1.01
10,000 .0005 .001 2.00 .5 .1 1,006 9 1.00
10,000 .01 .1 11 .5 .01 645 0 1.01
10,000 .009 .01 1.11 .5 .01 194 0 1.01
10,000 .001 .01 10.1 .5 .01 154 0 1.01
10,000 .0005 .01 20.2 .5 .01 151 8 1.01
10,000 .00005 .001 20.2 .5 .01 106 77 1.01
10,000 draw1 draw draw draw 0.01 731 –
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Table A.2: Mean coverage of nominal 95% intervals: Bayesian Multiple Imputation
vs Woolf ’s method.
1‘draw’ refers to drawing from the prior distribution of the parameters.
parameter values coverage
N p0 p1 !   ⇡
Bayesian MI
finite pop. super-pop. Woolf’s (!)
⌧ ! ⌧ !
10,000 .01 .01 1 .5 .01 .95 .95 .94 .94 .95
10,000 .005 .005 1 .5 .01 .94 .94 .94 .94 .94
10,000 .01 .005 .50 .5 .01 .96 .97 .96 .97 .96
10,000 .01 .005 .50 .3 .01 .95 .95 .95 .95 .96
10,000 .001 .0005 .50 .5 .01 .97 .96 .96 .97 .98
10,000 .001 .0005 .50 .5 .1 .95 .95 .96 .96 .98
10,000 .1 .01 .09 .5 .01 .95 .95 .95 .95 .95
10,000 .01 .009 .90 .5 .01 .95 .94 .94 .94 .95
10,000 .005 .01 2.01 .5 .01 .95 .95 .94 .94 .94
10,000 .005 .01 2.01 .3 .01 .94 .94 .95 .95 .95
10,000 .0005 .001 2.00 .5 .01 .96 .96 .95 .97 .98
10,000 .0005 .001 2.00 .5 .1 .95 .96 .96 .96 .98
10,000 .01 .1 11 .5 .01 .95 .95 .95 .95 .95
10,000 .009 .01 1.11 .5 .01 .96 .96 .96 .95 .96
10,000 .001 .01 11 .5 .01 .96 .96 .94 .96 .97
10,000 .0005 .01 20.2 .5 .01 .96 .95 .95 .98 .97
10,000 .00005 .001 20.2 .5 .01 .96 .96 .93 .88 .83
10,000 draw1 draw draw draw 0.01 .95 .95 .95 .95 –
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Table A.3: Mean absolute percent bias: Bayesian Multiple Imputation vs Woolf ’s
method.
⇤Mean absolute percent bias is ill-defined because ⌧ = 0.
parameter values mean abs. % bias
N p0 p1 !   ⇡
Bayesian MI
finite pop. super-pop. Woolf’s (!)
⌧ ! ⌧ !
10,000 .01 .01 1 .5 .01 –⇤ 23.6 –⇤ 24.3 23.4
10,000 .005 .005 1 .5 .01 –⇤ 30.3 –⇤ 32.7 30
10,000 .01 .005 .50 .5 .01 36.5 26.0 36.5 26.9 25.7
10,000 .01 .005 .50 .3 .01 36.6 29.3 35.9 30.2 29.8
10,000 .001 .0005 .50 .5 .01 120.9 88.0 115.1 167.4 86.0
10,000 .001 .0005 .50 .5 .1 130.1 76.7 272 148.3 76.7
10,000 .1 .01 .09 .5 .01 10.0 21.5 10.0 21.6 21.2
10,000 .01 .009 .90 .5 .01 254.1 24.7 99.2 1127.6 1079.1
10,000 .005 .01 2.01 .5 .01 38.5 28.1 38.6 29.9 28.0
10,000 .005 .01 2.01 .3 .01 46.1 29.2 46.0 30.5 29.9
10,000 .0005 .001 2.00 .5 .01 117.7 73.2 116.2 211.6 70.5
10,000 .0005 .001 2.00 .5 .1 112.2 70.7 111.9 206.4 69.1
10,000 .01 .1 11 .5 .01 10.3 21.3 10.3 21.9 21.5
10,000 .009 .01 1.11 .5 .01 221.1 23.7 212.3 23.7 22.8
10,000 .001 .01 11 .5 .01 16.3 60.7 16.2 118.3 58.4
10,000 .0005 .01 20.2 .5 .01 15.7 64.3 15.6 190.1 59.8
10,000 .00005 .001 20.2 .5 .01 51.5 39.5 43.6 41.8 76.3
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Table A.4: Mean width of nominal 95% intervals: Bayesian Multiple Imputation vs
Woolf ’s method.
parameter values mean interval width
N p0 p1 !   ⇡
Bayesian MI
finite pop. super-pop. Woolf’s (!)
⌧ ! ⌧ !
10,000 .01 .01 1 .5 .01 .01 1.04 .01 1.23 1.24
10,000 .01 .01 1 .5 .01 .01 1.26 .01 1.62 1.62
10,000 .01 .005 .50 .5 .01 .01 .56 .01 .68 .69
10,000 .01 .005 .50 .3 .01 .01 .67 .01 .77 .81
10,000 .001 .0005 .50 .5 .01 .00 2.05 .00 4.66 4.13
10,000 .001 .0005 .50 .5 .1 .00 1.81 .00 4.21 3.72
10,000 .1 .01 .09 .5 .01 .04 .09 .05 .10 .10
10,000 .01 .009 .90 .5 .01 .01 .97 .01 1.15 1.16
10,000 .005 .01 2.01 .5 .01 .01 2.31 .01 2.91 2.89
10,000 .005 .01 2.01 .3 .01 .01 2.46 .01 2.98 3.08
10,000 .0005 .001 2.00 .5 .01 .00 7.05 .00 24.95 16.65
10,000 .0005 .001 2.00 .5 .1 .00 6.40 .00 23.57 15.47
10,000 .01 .1 11 .5 .01 .04 10.64 .05 12.01 12.25
10,000 .009 .01 1.11 .5 .01 .01 1.15 .01 1.36 1.37
10,000 .001 .01 11 .5 .01 .01 23.92 .01 63.7 45.75
10,000 .0005 .01 20.2 .5 .01 .01 52.36 .01 220.6 133.12
10,000 .00005 .001 20.2 .5 .01 .00 14.37 .00 68.34 40.45
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A.3 Example prior specification, and posterior pre-
dictive draws for MVN extension model
A.3.1 Prior specification on ✓
p ⇠ Beta(2, 2) (A.27)
µ0 ⇠ MVN k(µ⇤,⌃⇤) (A.28)
⌃0 ⇠ Inv-Wishart(k + 1,⌃ ) (A.29)
µ1 ⇠ MVN (µ⇤,⌃⇤) (A.30)
⌃1 ⇠ Inv-Wishart(k + 1,⌃ ) (A.31)
 (0) ⇠ MVN (k+1)(µ†,⌃†) (A.32)
 (1) ⇠ MVN (k+1)(µ†,⌃†) (A.33)
(A.34)
104
Appendix A: Supplement to Chapter 2
where
µ⇤ = (0, · · · , 0)T (A.35)
⌃⇤ =
              
1000 0 . . . 0
0 1000 . . . 0
...
...
. . .
...
0 0 . . . 1000
              
(A.36)
⌃  =
              
1 0 . . . 0
0 1 . . . 0
...
...
. . .
...
0 0 . . . 1
              
(A.37)
µ† = (0, · · · , 0)T (A.38)
⌃† =
              
5 0 . . . 0
0 5 . . . 0
...
...
. . .
...
0 0 . . . 5
              
(A.39)
(A.40)
The Inverse Wishart prior above induces uniform marginal distributions for all
individual correlations (Barnard et al., 2000).
A.3.2 Imputation of Y˜
mis
: drawing from f(Y˜
mis|Y˜ obs,✓)
• For those units for which Sr, ·i = 1:
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1. If W ·, inci = 0:
Pr(Y mis, inci = 1|Y˜
obs
,✓) = Pr(Y mis, inci = 1|Y r, inci ,W ·, inci = 0,x·, inci , Sr,·i = 1,✓)
= Pr(Y mis, ·i = 1|Y r, ·i ,Wi = 0,xi, Sr, ·i = 1,✓)
=  (exi (1)) (A.41)
2. If W ·, inci = 1:
Pr(Y mis, inci = 1|Y˜
obs
,✓) = Pr(Y mis, inci = 1|Y r, inci ,W ·, inci = 0,x·, inci , Sr,·i = 1,✓)
= Pr(Y mis, ·i = 1|Y r, ·i ,Wi = 0,xi, Sr, ·i = 1,✓)
=  (exi (0)) (A.42)
• For those units for which Sr, ·i = 0:
Given ✓, independently for each i, draw sequentially from conditional distribu-
tions using the following:
1.
Pr(W ·, exci = 1|Y˜
obs
,✓) = Pr(W ·, exci = 1|Sr,·i = 0,✓)
=
p ·
h
1   
n eµT1  (1)p
1+ (1)T e⌃1 (1)
oi
p ·
h
1   
n eµT1  (1)p
1+ (1)T e⌃1 (1)
oi
+ (1  p) ·
h
1   
n eµT0  (0)p
1+ (0)T e⌃0 (0)
oi
(A.43)
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2.
Pr(x·, exci |Wi = 0, Y˜
obs
,✓) = Pr(x·, exci |Wi = 0, Sr,·i = 0,✓) (A.44)
=
(1   {exi (0)}) ·  k(xi;µ0,⌃0)
1   
n eµT0  (0)p
1+ (0)
T e⌃0 (0)
o (A.45)
Pr(x·, exci |Wi = 1, Y˜
obs
,✓) = Pr(x·, exci |Wi = 1, Sr,·i = 1,✓)
=
(1   {exi (1)}) ·  k(xi;µ1,⌃1)
1   
n eµT1  (1)p
1+ (1)
T e⌃1 (1)
o
We sample from the above two distributions via STAN.
3 . Let
P (i)(j,k)|w := Pr((Yi(0), Yi(1))
mis, exc = (j, k)|xi,Wi = w, Y˜ obs,✓)
= Pr((Yi(0), Yi(1))
mis, exc = (j, k)|xi,Wi = w, Sobsi = 0,✓) (A.46)
Then
P (i)(0,0)|0 = 1   (exi (1)) (A.47)
P (i)(0,0)|1 = 1   (exi (0)) (A.48)
P (i)(0,1)|0 =  (exi (1)) (A.49)
P (i)(1,0)|1 =  (exi (0)) (A.50)
P (i)(0,1)|1 = P
(i)
(1,0)|0 = P
(i)
(1,1)|0 = P
(i)
(1,1)|1 = 0 (A.51)
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B.1 Di↵erence in covariate means between control
and active treatment subgroups
Table B.1: T-test for di↵erence in covariate means between the two treatment groups,
post-matching (Section 3.2 analysis)
But for the variable prev.surg, t-tests suggest non-significant di↵erences in covariate
means between the two treatment groups, at the 0.05 significance level, post-matching.
Covariate t statistic p-value
type.surg -1.15 0.25
act.endoc 0.87 0.39
pre.HB -1.62 0.10
elective.surg 0.50 0.62
age -0.23 0.82
sex -0.22 0.83
area 0.06 0.95
plt.count 1.03 0.30
prev.surg 2.94 0.00
clinical 0.87 0.38
cad.risk 0.35 0.73
asst.dis 0.12 0.90
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B.2 Additional histograms
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Figure B.1: Histograms of selected covariates for control treatment group units, dis-
played by dataset.
Covariate distributions generally di↵er between population cohort units and sample
cohort units, as expected.
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pre.HB  (W=1; pop cohort)
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Figure B.2: Histograms of selected covariates for active treatment group units, dis-
played by dataset.
Covariate distributions generally di↵er between population cohort units and sample
cohort units, as expected.
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B.3 Zoomed plot of SDM for covariates for 20 im-
puted datasets
-4 -2 0 2 4
Standardized difference in means (SDM) for covariates
for 20 imputed datasets
asst.dis
cad.risk
clinical
prev.surg
plt.count
area
sex
age
elective.surg
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type.surg
|
|
|
|
|
|
|
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|
|
|
Initial (single imputation)
After matching (single imputation)
SDM over 20 imputations (I)
SDM over 20 imputations (AM)
Figure B.3: Standardized di↵erence in means, initial and after matching, for covari-
ates, for 20 imputed datasets.
Note that, to ensure fair before-after comparison, we standardize di↵erences in means
after matching, using the estimate of the variance of di↵erences in means before
matching. As such, displayed after matching statistics are not t-statistics in the con-
ventional sense.
Vertical lines appear at standardized di↵erences in means of -2, 0 and 2, respectively.
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B.4 PrepDA, step 1: computational details
We exploit the fact that, within the confines of our study, population cohort data
is known. We thus approximate Pr(Y˜
mis|Y˜ obs) with the empirical distribution of
Pr(Y˜
mis|Y˜ r, +), where Y˜ r, + = (Sr, ·,Y r, ·,W ,X) is the realized population cohort
data matrix, supplemented with the vector of realized sampling indicators, Sr, ·. To
sample from Pr(Y˜
mis|Y˜ obs), we sample, with replacement, N   ninc rows
R i := (Y
r, ·
i ,W
·, inc
i ,xi)
  
Y r, inci =0
, i 2 1, · · · , N,
from the realized population cohort data matrix.
A singly imputed realized population cohort dataset is obtained by appending the
set of sampled rows to the realized sample cohort dataset.
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B.5 Specification of logistic regression models
Model 1 was obtained by adding plt.count2, asst.dis2 and prev.surg2 to the model
resulting from backward model selection, starting with a model with all main e↵ects
and 2-way interaction terms, and using the BIC selection criteria. Its equation is as
follows:
Y ⇠ W + type.surg + pre.HB + age + sex area + plt.count
+ prev.surg + clinical + cad.risk + asst.dis + type.surg : area
+ pre.HB : age + pre.HB : sex + pre.HB : asst.dis + age : area
+ sex : area + area : plt.count + area : prev.surg + area : clinical
Model 2 was obtained by adding clinical2, type.surg2, prev.surg2, log(age) and age2
to the model resulting from backward model selection, starting with a model with all
main e↵ects and 2-way interaction terms, and using the AIC selection criteria. Its
equation is as follows:
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Y ⇠ W + type.surg + act.endoc + pre.HB + elective.surg + age + sex
+ area+ plt.count + prev.surg + clinical + cad.risk + asst.dis
+ type.surg : elective.surg + type.surg : sex + type.surg : area
+ type.surg : prev.surg + type.surg : cad.risk + type.surg : asst.dis
+ act.endoc : age + act.endoc : plt.count + act.endoc : asst.dis
+ pre.HB : age + pre.HB : sex + pre.HB : cad.risk + pre.HB : asst.dis
+ elective.surg : prev.surg + elective.surg : asst.dis + age : area
+ age : prev.surg + age : cad.risk + sex : area + sex : cad.risk
+ area : plt.count + area : prev.surg
+ area : clinical + plt.count : clinical + prev.surg : asst.dis
+ cad.risk : asst.dis (B.1)
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